Biology & Life Sciences

COVID-19 pandemic (2019-21)

Updated September 13, 2021 Curated Collections

This Collection of articles highlights all content published across the PLOS journals relating to the COVID-19 pandemic in 2019-21. PLOS is committed to disseminating research as quickly as possible, particularly in public health emergencies. All articles published in any PLOS journal are Open Access free of charge to all readers.

Image Credit: US NIH/Public domain (CC-0) and Senado Federal/Flickr (CC-BY)

Jump to section

Clinical Epidemiology and Care
Modelling, Forecasting, and Surveillance
Social Issues
Molecular and Genetic Studies
Hardware
Related Content
PLOS Collections

Clinical Epidemiology and Care

Image credit
Fig 1. Percentage of select characteristics among laboratory-confirmed COVID-19 patients with diabetes mellitus (DM), by hospitalization status (n = 54)—Colorado, March 2020 by Vahey et al., CC BY 4.0

PLOS ONE Risk factors for hospitalization among persons with COVID-19—Colorado
September 2, 2021 Grace M. Vahey, Emily McDonald, Kristen Marshall, Stacey W. Martin, Helen Chun, Rachel Herlihy, Jacqueline E. Tate, Breanna Kawasaki, Claire M. Midgley, Nisha Alden, Marie E. Killerby, J. Erin Staples, on behalf of the Colorado Investigation Team

Background: Most current evidence on risk factors for hospitalization because of coronavirus disease 2019 (COVID-19) comes from studies…
Image credit
Walking by Abhijit Kar Gupta, CC BY 2.0

PLOS ONE Pulmonary function and six-minute-walk test in patients after recovery from COVID-19: A prospective cohort study
September 2, 2021 Dararat Eksombatchai, Thananya Wongsinin, Thanyakamol Phongnarudech, Kanin Thammavaranucupt, Naparat Amornputtisathaporn, Somnuek Sungkanuparph

Objectives: To study abnormality of spirometry, six-minute walk distance, and chest radiograph among patients recovered from Coronavirus…
Image credit
Fig 2. Boxplots of significant differences in physiological respiratory parameters, hospital admissions and COVID-19 by Mälberg et al., CC BY 4.0

PLOS ONE Physiological respiratory parameters in pre-hospital patients with suspected COVID-19: A prospective cohort study
September 2, 2021 Johan Mälberg, Nermin Hadziosmanovic, David Smekal

Background: The COVID-19 pandemic has presented emergency medical services (EMS) worldwide with the difficult task of identifying patients…
Image credit
Fig 2. Rate of ICU admission, intubation, ECMO induction, and mortality according to group by Shionoya et al., CC BY 4.0

PLOS ONE Possibility of deterioration of respiratory status when steroids precede antiviral drugs in patients with COVID-19 pneumonia: A retrospective study
September 2, 2021 Yu Shionoya, Toshibumi Taniguchi, Hajime Kasai, Noriko Sakuma, Shun Imai, Kohei Shikano, Shin Takayanagi, Misuzu Yahaba, Taka-aki Nakada, Hidetoshi Igari, Seiichiro Sakao, Takuji Suzuki

Introduction: Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2. Although most patients with…
Image credit
Fig 1. Study area: To show where the region is located (sourced self) by Desta et al., CC BY 4.0

PLOS ONE Impacts of COVID-19 on essential health services in Tigray, Northern Ethiopia: A pre-post study
August 27, 2021 Abraham Aregay Desta, Tewolde Wubayehu Woldearegay, Estifanos Gebremeskel, Mussie Alemayehu, Theodros Getachew, Gebremedhin Gebregzabiher, Kiros Demoz Ghebremedhin, Degnesh Negash Zgita, Abera Berhe Aregawi, Getachew Redae

Background: COVID-19 has proved to have an indirect impact on essential health services in several parts of the world which could lead to…
Image credit
Fig 2. Assessment of methodological quality by Du et al., CC BY 4.0

PLOS ONE Add-on effect of Chinese herbal medicine in the treatment of mild to moderate COVID-19: A systematic review and meta-analysis
August 20, 2021 Xuqin Du, Lipeng Shi, Wenfu Cao, Biao Zuo, Aimin Zhou

Introduction: Coronavirus disease 2019 (COVID-19) has emerged as a global pandemic since its outbreak in Wuhan, China. It is an urgent task…
Image credit
Working place of a coronavirus vaccination center worker by Marco Verch, CC BY 2.0

PLOS ONE COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital
August 26, 2021 Katharina Pomej, Bernhard Scheiner, Lukas Hartl, Lorenz Balcar, Tobias Meischl, Mattias Mandorfer, Thomas Reiberger, Christian Müller, Michael Trauner, Matthias Pinter

Background: Patients with hepatocellular carcinoma (HCC) represent a vulnerable population potentially negatively affected by…
Image credit
Fig 1. ROC curve for D-dimer as a predictor of in-hospital mortality. by Poudel et al., CC BY 4.0

PLOS ONE D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19
August 26, 2021 Ayusha Poudel, Yashasa Poudel, Anurag Adhikari, Barun Babu Aryal, Debika Dangol, Tamanna Bajracharya, Anil Maharjan, Rakshya Gautam

Introduction: Coronavirus Disease 2019 is a primarily respiratory illness that can cause thrombotic disorders. Elevation of D-dimer is a…
Image credit
Fig 5. LM pathway analysis highlights upregulation of AA-derived LM in non-survivors patients by Palmas et al., CC BY 4.0

PLOS ONE Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients
August 26, 2021 Francesco Palmas, Jennifer Clarke, Romain A. Colas, Esteban A. Gomez, Aoife Keogh, Maria Boylan, Natalie McEvoy, Oliver J. McElvaney, Oisin McElvaney, Razi Alalqam, Noel G. McElvaney, Gerard F. Curley, Jesmond Dalli

Coronavirus disease (COVID)-19, as a result of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, has been the direct…
Image credit
Calendar by Dafne Cholet CC BY 2.0

PLOS ONE Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study
August 26, 2021 Arne Søraas, Karl Trygve Kalleberg, John Arne Dahl, Camilla Lund Søraas, Tor Åge Myklebust, Eyvind Axelsen, Andreas Lind, Roar Bævre-Jensen, Silje Bakken Jørgensen, Mette S. Istre, Eyrun F. Kjetland, Giske Ursin

Long-COVID-19 is a proposed syndrome negatively affecting the health of COVID-19 patients. We present data on self-rated health three to…
Image credit
Working place of a coronavirus vaccination center worker by Marco Verch, CC BY 2.0

PLOS ONE Health emergencies and interoceptive sensibility modulate the perception of non-evidence-based drug use: Findings from the COVID-19 outbreak
August 26, 2021 Gerardo Salvato, Daniela Ovadia, Alessandro Messina, Gabriella Bottini

Scientific evidence plays an important role in the therapeutic decision-making process. What happens when physicians are forced to make…
Image credit
Hand in medical gloves holding bottle with blue fluid on white background by Jernej Furman, CC BY 2.0

PLOS ONE Don’t close the book on tocilizumab for the treatment of severe COVID-19 pneumonia–the jury is still out: The Kuwait experience
August 24, 2021 Yousef Al-Shamali, Yaser M. Ali, Rawan A. Al-Shamali, Maryam Al-Melahi, Farah R. Al-Shammari, Ahmad Alsaber, Wasl Al-Adsani

Purpose: This cross-sectional observational study aims to report preliminary data from the first experience using tocilizumab for patients…
Image credit
Fig 1. VA distribution of the patients by Li et al., CC BY 4.0

PLOS ONE The impact of the COVID-19 pandemic lockdown on rhegmatogenous retinal detachment services—Experiences from the Tongren eye center in Beijing
August 19, 2021 Jipeng Li, Meng Zhao, Haicheng She, Aman Chandra

Purpose: To investigate the impact on services for rhegmatogenous retinal detachment (RRD) patients during the COVID-19 (2019coronal virus…
Image credit
Fig 4. Arrhythmogenic Ca2+ release in iPS-CM upon addition of COVID19 serum and treatment with Canakinumab by Dimai et al., CC BY 4.0

PLOS ONE COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab
August 19, 2021 Sanzio Dimai, Lukas Semmler, Ashok Prabhu, Harald Stachelscheid, Judith Huettemeister, Sandra C. Klaucke, Philipp Lacour, Florian Blaschke, Jan Kruse, Abdul Parwani, Leif-Hendrik Boldt, Lars Bullinger, Burkert M. Pieske, Frank R. Heinzel, Felix Hohendanner

Background: Cardiac injury associated with cytokine release frequently occurs in SARS-CoV-2 mediated coronavirus disease (COVID19) and…
Image credit
Fig 3. The violin/scatter plots depict the concern scores as a function of the Covid Impact for six health categories by Kurzhals et al., CC BY 4.0

PLOS ONE The impact of the Covid-19 pandemic on quality of life in skin cancer patients
August 18, 2021 Jonas K. Kurzhals, Gina Klee, Hauke Busch, Victoria Hagelstein, Detlef Zillikens, Patrick Terheyden, Ewan A. Langan

With more than 82 million cases worldwide and almost two million deaths, the Covid-19 global pandemic shows little sign of abating.…
Image credit
Fig 1. Clinical assessments and microbiology by year of admission by Butt et al., CC BY 4.0

PLOS ONE The impact of the COVID-19 pandemic on microbial keratitis presentation patterns
August 18, 2021 Gibran F. Butt, Alberto Recchioni, George Moussa, James Hodson, Graham R. Wallace, Philip I. Murray, Saaeha Rauz

Background: Microbial keratitis (MK) is the most common non-surgical ophthalmic emergency, and can rapidly progress, causing irreversible…
Image credit
Fig 1. Relative importance of predictors of cardiovascular involvement by Beck-Friis et al., CC BY 4.0

PLOS ONE No difference in biomarkers of ischemic heart injury and heart failure in patients with COVID-19 who received treatment with chloroquine phosphate and those who did not
August 16, 2021 Josefine Beck-Friis, Susannah Leach, Elmir Omerovic, Rickard Zeijlon, Magnus Gisslen, Aylin Yilmaz

Background: Chloroquine was promoted as a COVID-19 therapeutic early in the pandemic. Most countries have since discontinued the use of…
Image credit
Medical consultation by nursingschoolsnearme.com, CC BY 2.0

PLOS ONE Obesity is independently associated with septic shock, renal complications, and mortality in a multiracial patient cohort hospitalized with COVID-19
August 12, 2021 Gabrielle Page-Wilson, Rachel Arakawa, Samantha Nemeth, Fletcher Bell, Zachary Girvin, Mary-Claire Tuohy, Max Lauring, Blandine Laferrère, Gissette Reyes-Soffer, Karthik Natarajan, RuiJun Chen, Paul Kurlansky, Judith Korner

Background: Obesity has emerged as a risk factor for severe coronavirus disease 2019 (COVID-19) infection. To inform treatment…
Image credit
Fig 1. Geometric map of the emergency department showing the four-tier infection response system by Choi et al., CC BY 4.0

PLOS ONE Efficacy of a four-tier infection response system in the emergency department during the coronavirus disease-2019 outbreak
August 12, 2021 Arom Choi, Ha Yan Kim, Ara Cho, Jiyoung Noh, Incheol Park, Hyun Soo Chung

Introduction: The coronavirus disease (COVID-19) pandemic has delayed the management of other serious medical conditions. This study…
Image credit
Doctor chest with stethoscope in pocket by Authority Dental, CC BY 2.0

PLOS ONE Serological prevalence of SARS-CoV-2 infection and associated factors in healthcare workers in a “non-COVID” hospital in Mexico City
August 12, 2021 Esteban Cruz-Arenas, Elizabeth Cabrera-Ruiz, Sara Laguna-Barcenas, Claudia A. Colin-Castro, Tatiana Chavez, Rafael Franco-Cendejas, Clemente Ibarra, Javier Perez-Orive

Background: Mexico is one of the countries with the highest number of deaths from the COVID-19 pandemic. In spite of this high mortality,…
Image credit
Fig 1. Mortality rate due to COVID-19 in Brazil and regions in the period from 12ª to 53ª epidemiological week by Costa et al., CC BY 4.0

PLOS ONE Evaluation of the epidemiological behavior of mortality due to COVID-19 in Brazil: A time series study
August 12, 2021 Ketyllem Tayanne da Silva Costa, Thiffany Nayara Bento de Morais, Dayane Caroliny Pereira Justino, Fábia Barbosa de Andrade

The World Health Organization declared, at the end of 2019, a pandemic caused by SARS-CoV-2, a virus that causes Coronavirus…
Image credit
Stethoscope, pills, and syringe on white table by Authority Dental, CC BY 2.0

PLOS ONE Changes in the top 25 reasons for primary care visits during the COVID-19 pandemic in a high-COVID region of Canada
August 12, 2021 Ellen Stephenson, Debra A. Butt, Jessica Gronsbell, Catherine Ji, Braden O’Neill, Noah Crampton, Karen Tu

Purpose: We aimed to determine the degree to which reasons for primary care visits changed during the COVID-19 pandemic. Methods: We used…
Image credit
Fig 1. Interleukin (IL)-6 levels and severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) RNA copy number in plasma on admission, receiver operating characteristic (ROC) analysis for combined different variables by Saji et al., CC BY 4.0

PLOS ONE Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19
August 11, 2021 Ryo Saji, Mototsugu Nishii, Kazuya Sakai, Kei Miyakawa, Yutaro Yamaoka, Tatsuma Ban, Takeru Abe, Yutaro Ohyama, Kento Nakajima, Taro Hiromi, Reo Matsumura, Naoya Suzuki, Hayato Taniguchi, Tsuyoshi Otsuka, Yasufumi Oi, Fumihiro Ogawa, Munehito Uchiyama, Kohei Takahashi, Masayuki Iwashita, Yayoi Kimura, Satoshi Fujii, Ryosuke Furuya, Tomohiko Tamura, Akihide Ryo, Ichiro Takeuchi

Background: The coronavirus disease 2019 (COVID-19) pandemic rapidly increases the use of mechanical ventilation (MV). Such cases further…
Image credit
Fig 1. Description of the cohort by Shoaib et al., CC BY 4.0

PLOS ONE COVID-19 severity: Studying the clinical and demographic risk factors for adverse outcomes
August 11, 2021 Naila Shoaib, Naila Noureen, Rimsha Munir, Farhad Ali Shah, Noshaba Ishtiaq, Nazia Jamil, Rida Batool, Mohammad Khalid, Ihsan Khan, Naser Iqbal, Nousheen Zaidi

Background: The primary goal of the presented cross-sectional observational study was to determine the clinical and demographic risk…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases/NIH, CC-0 Public Domain

PLOS ONE COVID-19 and cause of pregnancy loss during the pandemic: A systematic review
August 11, 2021 Seyyedeh Neda Kazemi, Bahareh Hajikhani, Hamidreza Didar, Sareh Sadat Hosseini, Sara Haddadi, Farima Khalili, Mehdi Mirsaeidi, Mohammad Javad Nasiri

Introduction: The association between Coronavirus Disease 2019 (COVID-19) and abortion has been debated since the beginning of the COVID-19…
Image credit
Intravenous therapy (IV) drip by Robert Geiger, CC BY 2.0

PLOS ONE The tumor patient in the COVID-19 pandemic–an interview-based study of 30 patients undergoing systemic antiproliferative therapy
August 11, 2021 Ulrich Kaiser, Ursula Vehling-Kaiser, Jörg Schmidt, Ana Hoffmann, Florian Kaiser

Introduction: Five months after COVID-19 first occurred and protective regulations were introduced, patients at three outpatient…
PLOS ONE Characteristics and outcomes of acute kidney injury in hospitalized COVID-19 patients: A multicenter study by the Turkish society of nephrology
August 10, 2021 Hakki Arikan, Savas Ozturk, Bulent Tokgoz, Belda Dursun, Nurhan Seyahi, Sinan Trabulus, Mahmud Islam, Yavuz Ayar, Numan Gorgulu, Serhat Karadag, Mahmut Gok, Esra Akcali, Feyza Bora, Zeki Aydın, Eda Altun, Elbis Ahbap, Mehmet Polat, Zeki Soypacacı, Ebru Gok Oguz, Sumeyra Koyuncu, Hulya Colak, İdris Sahin, Murside Esra Dolarslan, Ozant Helvacı, Ilhan Kurultak, Zehra Eren, Hamad Dheir, Melike Betul Ogutmen, Dilek Guven Taymez, Dilek Gibyeli Genek, Sultan Ozkurt, Elif Ari Bakır, Enver Yuksel, Tuncay Sahutoglu, Ozgur Akin Oto, Gulsah Boz, Erkan Sengul, Ekrem Kara, Serhan Tuglular

Background: Acute kidney injury (AKI) is common in coronavirus disease-2019 (COVID-19) and the severity of AKI is linked to adverse…
Image credit
Fig 2. Impact of type I IFN-α treatment on SARS-CoV-2-induced weight loss and viral titers by Bessière et al., CC BY 4.0

PLOS Pathogens Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model
August 9, 2021 Pierre Bessière, Marine Wasniewski, Evelyne Picard-Meyer, Alexandre Servat, Thomas Figueroa, Charlotte Foret-Lucas, Amelia Coggon, Sandrine Lesellier, Frank Boué, Nathan Cebron, Blandine Gausserès, Catherine Trumel, Gilles Foucras, Francisco J. Salguero, Elodie Monchatre-Leroy, Romain Volmer

Impaired type I interferons (IFNs) production or signaling have been associated with severe COVID-19, further promoting the evaluation of…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, Public Domain Mark 1.0

PLOS Biology Challenges in interpreting cytokine data in COVID-19 affect patient care and management
August 6, 2021 Stephen Y. Wang, Takehiro Takahashi, Alexander B. Pine, William E. Damsky, Michael Simonov, Yanhua Zhang, Elizabeth Kieras, Christina C. Price, Brett A. King, Mark D. Siegel, Gary V. Desir, Alfred I. Lee, Akiko Iwasaki, Hyung J. Chun

Challenges in using cytokine data are limiting Coronavirus Disease 2019 (COVID-19) patient management and comparison among different…
Image credit
Fig 2. ROC analysis of hematological parameters in the diagnosis of severe COVID-19 patients by Kilercik et al., CC BY 4.0

PLOS ONE A new haematocytometric index: Predicting severity and mortality risk value in COVID-19 patients
August 5, 2021 Meltem Kilercik, Özlem Demirelce, Muhittin Abdulkadir Serdar, Parvana Mikailova, Mustafa Serteser

Introduction: Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 virus, is a major public health concern spanning from healthy…
Image credit
Fig 4. Multivariable logistic regression analysis for 180-day all-cause mortality after hospital admission by Günster et al., CC BY 4.0

PLOS ONE 6-month mortality and readmissions of hospitalized COVID-19 patients: A nationwide cohort study of 8,679 patients in Germany
August 5, 2021 Christian Günster, Reinhard Busse, Melissa Spoden, Tanja Rombey, Gerhard Schillinger, Wolfgang Hoffmann, Steffen Weber-Carstens, Andreas Schuppert, Christian Karagiannidis

Background: COVID-19 frequently necessitates in-patient treatment and in-patient mortality is high. Less is known about the long-term…
Image credit
Fig 1. Study design and estimated pregnancy trimester of SARS-CoV-2 infection by Cosma et al. , CC BY 4.0

PLOS ONE Preterm birth is not associated with asymptomatic/mild SARS-CoV-2 infection per se: Pre-pregnancy state is what matters
August 5, 2021 Stefano Cosma, Andrea Roberto Carosso, Jessica Cusato, Fulvio Borella, Marco Carosso, Fiammetta Gervasoni, Ilaria Stura, Mario Preti, Valeria Ghisetti, Giovanni Di Perri, Chiara Benedetto

Evidence for the real impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on preterm birth is unclear, as…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, Public Domain Mark 1.0

PLOS ONE Anxious temperament and cyberchondria as mediated by fear of COVID-19 infection: A cross-sectional study
August 5, 2021 Włodzimierz Oniszczenko

This study’s main goal was to evaluate the association between anxious temperament and the fear of COVID-19-related self-infection and…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, Public Domain Mark 1.0

PLOS Neglected Tropical Diseases Use of minimally invasive autopsy during the COVID-19 pandemic and its possibilities in the context of developing countries
August 4, 2021 Deborah Nunes Melo, Tania Mara Coelho, Giovanna Rolim Pinheiro Lima, Carolina Gomes Fernandes, Bruno Cavalcante Fales de Brito Alves, Fernanda Montenegro de Carvalho Araújo, Renata Aparecida de Almeida Monteiro, Jaume Ordi, Paulo Hilário do Nascimento Saldiva, Luciano Pamplona de Góes Cavalcanti

…
Image credit
New Monitor/New Desk by Dave Fayram, CC BY 2.0

PLOS ONE Application of telemedicine in the COVID-19 epidemic: An analysis of Gansu Province in China
August 4, 2021 Yan Wang, Jie Yang, Huijuan Ma, Xinchun Dong, Guangmei Xie, Songning Ye, Juan Du

This paper analyzes the application of various telemedicine services in Gansu Province, China during the COVID-19 epidemic, and summarizes…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID/NIH, CC-0 Public Domain

PLOS ONE In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain
August 3, 2021 Inés Suárez-García, Isabel Perales-Fraile, Andrés González-García, Arturo Muñoz-Blanco, Luis Manzano, Martín Fabregate, Jesús Díez-Manglano, Eva Fonseca Aizpuru, Francisco Arnalich Fernández, Alejandra García García, Ricardo Gómez-Huelgas, José-Manuel Ramos-Rincón, on behalf of SEMI-COVID-19 Network

Background: Whether immunosuppressed (IS) patients have a worse prognosis of COVID-19 compared to non-IS patients is not known. The aim of…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID/NIH, CC-0 Public Domain

PLOS ONE Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients
August 3, 2021 Susan M. Taghioff, Benjamin R. Slavin, Tripp Holton, Devinder Singh

Introduction: Recently, several single center studies have suggested a protective effect of the influenza vaccine against severe acute…
Image credit
Fig 4. Directed acyclic graph describing relationships between the COVID-19 pandemic and a reduction in COPD exacerbations by Alqahtani et al., CC BY 4.0

PLOS ONE Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis
August 3, 2021 Jaber S. Alqahtani, Tope Oyelade, Abdulelah M. Aldhahir, Renata Gonçalves Mendes, Saeed M. Alghamdi, Marc Miravitlles, Swapna Mandal, John R. Hurst

Background: Reports have suggested a reduction in exacerbations of chronic obstructive pulmonary disease (COPD) during the coronavirus…
Image credit
Fig 2. Hospitalized COVID-19 patients in Houston Trauma Service Area (TSA-Q) and Houston Methodist Hospital System over time by Sandoval et al., CC BY 4.0

PLOS ONE Risk factors for severity of COVID-19 in hospital patients age 18–29 years
July 30, 2021 Micaela Sandoval, Duc T. Nguyen, Farhaan S. Vahidy, Edward A. Graviss

Background: Since February 2020, over 2.5 million Texans have been diagnosed with COVID-19, and 20% are young adults at risk for SARS-CoV-2…
Image credit
Image title by agilemktg1, Public Domain Mark 1.0

PLOS ONE Trends in COVID-19 cases and clinical management in Veterans Health Administration medical facilities: A national cohort study
July 29, 2021 Maya Aboumrad, Brian Shiner, Natalie Riblet, Hugh Huizenga, Nabin Neupane, Yinong Young-Xu

Objective: We explored longitudinal trends in sociodemographic characteristics, reported symptoms, laboratory findings, pharmacological and…
Image credit
Fig 1. Timeline of the study by Arévalos et al., CC BY 4.0

PLOS ONE Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol
July 29, 2021 Victor Arévalos, Luis Ortega-Paz, Diego Fernandez-Rodríguez, Víctor Alfonso Jiménez-Díaz, Jordi Bañeras Rius, Gianluca Campo, Miguel Rodríguez-Santamarta, Armando Pérez de Prado, Antonio Gómez-Menchero, José Francisco Díaz Fernández, Claudia Scardino, Nieves Gonzalo, Alberto Pernigotti, Fernando Alfonso, Ignacio Jesús Amat-Santos, Antonio Silvestro, Alfonso Ielasi, José María de la Torre, Gabriela Bastidas, Josep Gómez-Lara, Manel Sabaté, Salvatore Brugaletta, on behalf of the CV COVID-19 Registry Investigators

Background: Patients presenting with the coronavirus-2019 disease (COVID-19) may have a high risk of cardiovascular adverse events,…
Image credit
Fig 2 by Wilde et al., CC BY 4.0

PLOS ONE A national retrospective study of the association between serious operational problems and COVID-19 specific intensive care mortality risk
July 29, 2021 Harrison Wilde, John M. Dennis, Andrew P. McGovern, Sebastian J. Vollmer, Bilal A. Mateen

Objectives: To describe the relationship between reported serious operational problems (SOPs), and mortality for patients with COVID-19…
Image credit
Fig 4. Schematic illustration of SARS-CoV-2 infection and the role of HIF − 1α on SARS-CoV-2 pathogenesis by Habibi et al., CC BY 4.0

PLOS ONE Topological network based drug repurposing for coronavirus 2019
July 29, 2021 Mahnaz Habibi, Golnaz Taheri

The COVID-19 pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has become the current health concern and…
Image credit
Fig 1. Pre-pandemic versus pandemic hospital LOS from POD 0–10 for craniotomy and endonasal cohorts by Mallari et al., CC BY 4.0

PLOS ONE Streamlining brain tumor surgery care during the COVID-19 pandemic: A case-control study
July 29, 2021 Regin Jay Mallari, Michael B. Avery, Alex Corlin, Amalia Eisenberg, Terese C. Hammond, Neil A. Martin, Garni Barkhoudarian, Daniel F. Kelly

Background: The COVID-19 pandemic forced a reconsideration of surgical patient management in the setting of scarce resources and risk of…
Image credit
Fig 2. Survival curves adjusted for active leprosy and COVID-19 positive household contact representing possible risk factors for the occurrence of COVID-19. by Vinicius et al., CC BY 4.0

PLOS Neglected Tropical Diseases The influence of leprosy-related clinical and epidemiological variables in the occurrence and severity of COVID-19: A prospective real-world cohort study
July 28, 2021 Selma Regina Penha Silva Cerqueira, Patrícia Duarte Deps, Débora Vilela Cunha, Natanael Victor Furtunato Bezerra, Daniel Holanda Barroso, Ana Bárbara Sapienza Pinheiro, Gecilmara Salviato Pillegi, Taynah Alves Rocha Repsold, Patrícia Shu Kurizky, Simon M. Collin, Ciro Martins Gomes

Background: Protective effects of Bacillus Calmette–Guérin (BCG) vaccination and clofazimine and dapsone treatment against severe acute…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, Public Domain Mark 1.0

PLOS ONE High mortality among kidney transplant recipients diagnosed with coronavirus disease 2019: Results from the Brazilian multicenter cohort study
July 28, 2021 Lúcio R. Requião-Moura, Tainá Veras de Sandes-Freitas, Laila Almeida Viana, Marina Pontello Cristelli, Luis Gustavo Modelli de Andrade, Valter Duro Garcia, Claudia Maria Costa de Oliveira, Ronaldo de Matos Esmeraldo, Mario Abbud Filho, Alvaro Pacheco-Silva, Katia Cronemberger Sousa, Alessandra Rosa Vicari, Kellen Micheline Alves Henrique Costa, Denise Rodrigues Simão, Marcos Vinicius de Sousa, Juliana Bastos Campos, Ricardo Augusto Monteiro de Barros Almeida, Luciane Mônica Deboni, Miguel Moysés Neto, Juliana Aparecida Zanocco, Helio Tedesco-Silva, José Medina-Pestana, on behalf of COVID-19-KT Brazil

Background: Kidney transplant (KT) recipients are considered a high-risk group for unfavorable outcomes in the course of coronavirus…
Image credit
Fig 3 by Briggs et al., CC BY 4.0

PLOS ONE Early but not late convalescent plasma is associated with better survival in moderate-to-severe COVID-19
July 28, 2021 Neima Briggs, Michael V. Gormally, Fangyong Li, Sabrina L. Browning, Miriam M. Treggiari, Alyssa Morrison, Maudry Laurent-Rolle, Yanhong Deng, Jeanne E. Hendrickson, Christopher A. Tormey, Mahalia S. Desruisseaux

Background: Limited therapeutic options exist for coronavirus disease 2019 (COVID-19). COVID-19 convalescent plasma (CCP) is a potential…
Image credit
3D-printed physical model of SARS-CoV-2 by NIH, Public Domain 1.0

PLOS ONE Lower serum 25(OH)D levels associated with higher risk of COVID-19 infection in U.S. Black women
July 27, 2021 Yvette C. Cozier, Nelsy Castro-Webb, Natasha S. Hochberg, Lynn Rosenberg, Michelle A. Albert, Julie R. Palmer

Objective: Limited evidence suggests that higher levels of serum vitamin D (25(OH)D) protect against SARS-CoV-2 virus (COVID-19) infection.…
Image credit
Fig 4. Cumulative frequency of observed sedation depth by Flinspach et al., CC BY 4.0

PLOS ONE High sedation needs of critically ill COVID-19 ARDS patients—A monocentric observational study
July 27, 2021 Armin Niklas Flinspach, Hendrik Booke, Kai Zacharowski, Ümniye Balaban, Eva Herrmann, Elisabeth Hannah Adam

Background: Therapy of severely affected coronavirus patient, requiring intubation and sedation is still challenging. Recently,…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID/NIH, Public Domain Mark 1.0

PLOS ONE COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry
July 27, 2021 Gabriel Bsteh, Hamid Assar, Harald Hegen, Bettina Heschl, Fritz Leutmezer, Franziska Di Pauli, Christiane Gradl, Gerhard Traxler, Gudrun Zulehner, Paulus Rommer, Peter Wipfler, Michael Guger, Christian Enzinger, Thomas Berger, for the AUT-MuSC investigators

Background: The COVID-19 pandemic challenges neurologists in counselling patients with multiple sclerosis (pwMS) regarding their risk by…
Image credit
Fig 2. Receiver operating characteristic (ROC) curve is showing the relative diagnostic performances of creatinine, CRP, D-dimer, ferritin, neutrophils, and SGPTA by Rahman et al., CC BY 4.0

PLOS ONE Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: Experience from Bangladesh
July 27, 2021 Md. Ashrafur Rahman, Yeasna Shanjana, Md. Ismail Tushar, Tarif Mahmud, Ghazi Muhammad Sayedur Rahman, Zahid Hossain Milan, Tamanna Sultana, Ali Mohammed Lutful Hoq Chowdhury, Mohiuddin Ahmed Bhuiyan, Md. Rabiul Islam, Hasan Mahmud Reza

Background: The hematological abnormalities are assumed to be involved in the disease progression of COVID-19. However, the actual…
Image credit
Fig 1. Brazil political-geographic map showing its federative units (states), and the location of the participating centers of REBRACO by Costa et al., CC BY 4.0

PLOS ONE Facing the COVID-19 pandemic inside maternities in Brazil: A mixed-method study within the REBRACO initiative
July 23, 2021 Maria Laura Costa, Renato T. Souza, Rodolfo C. Pacagnella, Silvana F. Bento, Carolina C. Ribeiro-do-Valle, Adriana G. Luz, Giuliane J. Lajos, Guilherme M. Nobrega, Thayna B. Griggio, Charles M. Charles, Ricardo P. Tedesco, Karayna G. Fernandes, Sérgio H. A. Martins-Costa, Frederico J. A. Peret, Francisco E. Feitosa, Rosiane Mattar, Edson V. Cunha Filho, Janete Vetorazzi, Samira M. Haddad, Carla B. Andreucci, José P. Guida, Mário D. Correa Junior, Marcos A. B. Dias, Leandro G. Oliveira, Elias F. Melo Junior, Carlos A. S. Menezes, Marília G. Q. Luz, Jose G. Cecatti, for the REBRACO Study Group

Introduction: COVID-19 pandemic posed major challenges in obstetric health care services. Preparedness, development, and implementation of…
Image credit
Fig 1. Bayesian reanalysis of clinical trials testing the efficacy of remdesivir against COVID-19 by Hoek et al., CC BY 4.0

PLOS ONE Rethinking remdesivir for COVID-19: A Bayesian reanalysis of trial findings
July 23, 2021 Joyce M. Hoek, Sarahanne M. Field, Ymkje Anna de Vries, Maximilian Linde, Merle-Marie Pittelkow, Jasmine Muradchanian, Don van Ravenzwaaij

Background: Following testing in clinical trials, the use of remdesivir for treatment of COVID-19 has been authorized for use in parts of…
Image credit
Fig 1. Experimental model simulating endoscopic examination by Keil et al., CC BY 4.0

PLOS ONE Commonly available but highly effective protection against SARS-CoV-2 during gastrointestinal endoscopies
July 23, 2021 Radan Keil, Štěpán Hlava, Petr Stanovský, Vladimír Ždímal, Jan Šťovíček, Milan Trojánek, Jiří Drábek, Barbora Frýbová, Vojtěch Petráček, Martin Wasserbauer

Background and aims: SARS-CoV-2 is a worldwide serious health problem. The aim of this study was to demonstrate the number of potentially…
Image credit
Fig 1. Clinical features of the cohort by Meis-Pinheiro et al., CC BY 4.0

PLOS ONE Clinical characteristics of COVID-19 in older adults. A retrospective study in long-term nursing homes in Catalonia
July 23, 2021 Uxío Meis-Pinheiro, Francesc Lopez-Segui, Sandra Walsh, Anton Ussi, Sebastia Santaeugenia, Jose Augusto Garcia-Navarro, Antonio San-Jose, Antoni L. Andreu, Magda Campins, Benito Almirante

The natural history of COVID-19 and predictors of mortality in older adults need to be investigated to inform clinical operations and…
Image credit
Fig 3. Laboratory tests of dialysis patients with COVID19 with comparison of baseline and day 7 (for lymphocyte and Albumin levels) and baseline and peak value (for WBC, ferritin, CRP and IL-6) by Ghonimi et al., CC BY 4.0

PLOS ONE Mortality and associated risk factors of COVID-19 infection in dialysis patients in Qatar: A nationwide cohort study
July 22, 2021 Tarek Abdel Latif Ghonimi, Mohamad Mahmood Alkad, Essa Abdulla Abuhelaiqa, Muftah M. Othman, Musab Ahmed Elgaali, Rania Abdelaziz M. Ibrahim, Shajahan M. Joseph, Hassan Ali Al-Malki, Abdullah Ibrahim Hamad

Context: Patients on maintenance dialysis are more susceptible to COVID-19 and its severe form. We studied the mortality and associated…
Image credit
Fig 2. Frequency of severe COVID-19 (death/ICU/ hospitalization ≥10 days) by pre-infection fasting blood glucose, among patients with (in black) and without (in grey) a diagnosis of diabetes by Shauly-Aharonov et al., CC BY 4.0

PLOS ONE Both high and low pre-infection glucose levels associated with increased risk for severe COVID-19: New insights from a population-based study
July 22, 2021 Michal Shauly-Aharonov, Asher Shafrir, Ora Paltiel, Ronit Calderon-Margalit, Rifaat Safadi, Roee Bicher, Orit Barenholz-Goultschin, Joshua Stokar

Importance: Patients with diabetes are known to be at increased risk for infections including severe coronavirus disease 2019 (COVID-19)…
Image credit
Image title by National Institute of Allergy and Infectious Diseases, NIH, Public Domain Mark 1.0

PLOS ONE The impact of medical teleconsultations on general practitioner-patient communication during COVID- 19: A case study from Poland
July 16, 2021 Magdalena Kludacz-Alessandri, Liliana Hawrysz, Piotr Korneta, Grażyna Gierszewska, Wioletta Pomaranik, Renata Walczak

According to the outbreak of the Covid-19 pandemic, medical teleconsultations using various technologies have become an important tool to…
Image credit
Fig 1. Source of information about COVID-19 among the outpatient service visitors at Debre Markos compressive specialized hospital, Amhara regional state, Ethiopia, 2020 by Feleke et al., CC BY 4.0

PLOS ONE Knowledge, attitude and preventive practice towards COVID-19 and associated factors among outpatient service visitors at Debre Markos compressive specialized hospital, north-west Ethiopia, 2020
July 15, 2021 Bekele Taye Feleke, Mengistu Zelalem Wale, Mesenbet Terefe Yirsaw

Background: COVID-19 is an emerging infectious disease which is a major public health problem worldwide. Given the serious threats imposed…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID/NIH, Public Domain Mark 1.0

PLOS ONE Manifestations of renal system involvement in hospitalized patients with COVID-19 in Saudi Arabia
July 15, 2021 Khaled S. Allemailem, Ahmad Almatroudi, Amjad Ali Khan, Arshad H. Rahmani, Ibrahim S. Almarshad, Fahad S. Alekezem, Nagwa Hassanein, Asmaa M. El-Kady

Background: Although COVID-19 is an acute disease that usually resolves rapidly in most cases, the disease can be fatal and has a mortality…
Image credit
Image title by NIAID/NIH, Public Domain Mark 1.0

PLOS ONE Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry
July 15, 2021 Lori B. Daniels, Junting Ren, Kris Kumar, Quan M. Bui, Jing Zhang, Xinlian Zhang, Mariem A. Sawan, Howard Eisen, Christopher A. Longhurst, Karen Messer

Background: Statins have anti-inflammatory and immunomodulatory effects that may reduce the severity of coronavirus disease 2019…
Image credit
Fig 2. The proportion of municipalities attended by TRS in Brazil by region by Montelongo et al., CC BY 4.0

PLOS ONE The management of COVID-19 cases through telemedicine in Brazil
July 14, 2021 Alfredo Montelongo, João Luiz Becker, Rudi Roman, Elise Botteselle de Oliveira, Roberto Nunes Umpierre, Marcelo Rodrigues Gonçalves, Rodolfo Silva, Katarzyna Doniec, Ali K. Yetisen

In Dec 2020 Brazil became one of the worldwide epicenters of the COVID-19 pandemic with more than 7.2M reported cases. Brazil has a large…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, Public Domain 1.0

PLOS ONE Pre-hospital causes for delayed arrival in acute ischemic stroke before and during the COVID-19 pandemic: A study at two stroke centers in Egypt
July 14, 2021 Hany M. Aref, Hossam Shokri, Tamer M. Roushdy, Fatma Fathalla, Nevine M. El Nahas

Background: In the current study we investigated the causes of pre-hospital delay as this can compromise the patient’s chance to receive…
Image credit
Fig 1. Immune response to SARS-CoV-2 infection model schematic by Jenner et al., CC BY 4.0

PLOS Pathogens COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes
July 14, 2021 Adrianne L. Jenner, Rosemary A. Aogo, Sofia Alfonso, Vivienne Crowe, Xiaoyan Deng, Amanda P. Smith, Penelope A. Morel, Courtney L. Davis, Amber M. Smith, Morgan Craig

To understand the diversity of immune responses to SARS-CoV-2 and distinguish features that predispose individuals to severe COVID-19, we…
Image credit
bacteria/viruses by John Voo, CC BY 2.0

PLOS ONE Bacterial superinfection in adults with COVID-19 hospitalized in two clinics in Medellín-Colombia, 2020
July 13, 2021 Juan Carlos Cataño-Correa, Jaiberth Antonio Cardona-Arias, Jessica Paola Porras Mancilla, Marcela Tabares García

COVID-19 represents high morbidity and mortality, its complications and lethality have increased due to bacterial superinfections. We…
Image credit
Fig 2. Outcome of the patients in each group by Miki et al., CC BY 4.0

PLOS ONE On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19
July 13, 2021 Shoji Miki, Hiroaki Sasaki, Hiroshi Horiuchi, Nobuyuki Miyata, Yukihiro Yoshimura, Kazuhito Miyazaki, Takayuki Matsumura, Yoshimasa Takahashi, Tadaki Suzuki, Tetsuro Matano, Ai Kawana-Tachikawa, Natsuo Tachikawa

Background: This study aimed to clarify how SARS-CoV-2 RNAemia is related to COVID-19 critical condition development and mortality in…
Image credit
Jefferson City Medical Group could help with shortage of flu shots by KOMUnews, CC BY 2.0

PLOS ONE Intention to receive vaccine against COVID-19 and associated factors among health professionals working at public hospitals in resource limited settings
July 12, 2021 Mohammedjud Hassen Ahmed, Shuma Gosha Kanfe, Mohammedamin Hajure Jarso

Backgrounds: Health professionals are among the frontline of COVID-19 pandemic exposure and identified as a priority target group that need…
Image credit
Inauguración del Hospital Municipal de Chiconcuac by Presidencia de la República Mexicana, CC BY 2.0

PLOS ONE Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study
July 12, 2021 Dominik Menges, Tala Ballouz, Alexia Anagnostopoulos, Hélène E. Aschmann, Anja Domenghino, Jan S. Fehr, Milo A. Puhan

Background: Longer-term consequences after SARS-CoV-2 infection are becoming an important burden to societies and healthcare systems. Data…
Image credit
Fig 1. Subgroup breakdown for analyses. by Brojakowska et al., CC BY 4.0

PLOS ONE Comorbidities, sequelae, blood biomarkers and their associated clinical outcomes in the Mount Sinai Health System COVID-19 patients
July 6, 2021 Agnieszka Brojakowska, Abrisham Eskandari, Malik Bisserier, Jeffrey Bander, Venkata Naga Srikanth Garikipati, Lahouaria Hadri, David A. Goukassian, Kenneth M. Fish

With the continuing rise of SARS-CoV2 infection globally and the emergence of various waves in different countries, understanding…
Image credit
Fig 1. Weekly incidence and 95% confidence intervals of elective surgeries in 2020 and in the reference years. by Uimonen et al., CC BY 4.0

PLOS ONE The impact of the COVID-19 pandemic on waiting times for elective surgery patients: A multicenter study
July 6, 2021 Mikko Uimonen, Ilari Kuitunen, Juha Paloneva, Antti P. Launonen, Ville Ponkilainen, Ville M. Mattila

Background: A concern has been that health care reorganizations during the first COVID-19 wave have led to delays in elective surgeries,…
Image credit
Fig 3. Clinical parameters during the 7-day study period. by Kim et al., CC BY 4.0

PLOS ONE Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study
July 2, 2021 Won-Young Kim, Oh Joo Kweon, Min Jae Cha, Moon Seong Baek, Seong-Ho Choi

Dexamethasone provides benefits in patients with coronavirus disease 2019 (COVID-19), although data regarding immunological profiles and…
Image credit
Fig 3. Impact of COVID-19 on nursing care processes and care delivery. by Anton et al., CC BY 4.0

PLOS ONE Identifying factors that nurses consider in the decision-making process related to patient care during the COVID-19 pandemic
July 2, 2021 Nicholas Anton, Tera Hornbeck, Susan Modlin, Md Munirul Haque, Megan Crites, Denny Yu

Background: Nurse identification of patient deterioration is critical, particularly during the COVID-19 pandemic, as patients can…
Image credit
Fig 1. S1 IgM titres in COVID-19 patients (recovered and deceased) and asymptomatic subjects. by Marchi et al., CC BY 4.0

PLOS ONE Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection
July 2, 2021 Serena Marchi, Simonetta Viviani, Edmond J. Remarque, Antonella Ruello, Emilio Bombardieri, Valentina Bollati, Gregorio P. Milani, Alessandro Manenti, Giulia Lapini, Annunziata Rebuffat, Emanuele Montomoli, Claudia M. Trombetta

SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with unprecedented strain on health care systems. To…
Image credit
Fig 1. Illustration of the modeling framework. by Mahdavi et al., CC BY 4.0

PLOS ONE A machine learning based exploration of COVID-19 mortality risk
July 2, 2021 Mahdi Mahdavi, Hadi Choubdar, Erfan Zabeh, Michael Rieder, Safieddin Safavi-Naeini, Zsolt Jobbagy, Amirata Ghorbani, Atefeh Abedini, Arda Kiani, Vida Khanlarzadeh, Reza Lashgari, Ehsan Kamrani

Early prediction of patient mortality risks during a pandemic can decrease mortality by assuring efficient resource allocation and…
Image credit
Fig 2. Relationship between new COVID-19 cases per 100,000 (cumulative rate per month) and national sales volumes of antibiotics, azithromycin, doxycycline, faropenem, and HCQ from January to December 2020. by Sulis et al., CC BY 4.0

PLOS Medicine Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis
July 1, 2021 Giorgia Sulis, Brice Batomen, Anita Kotwani, Madhukar Pai, Sumanth Gandra

Background: We assessed the impact of the coronavirus disease 2019 (COVID-19) epidemic in India on the consumption of antibiotics and…
Image credit
Fig 6. by Seeßle et al., CC BY 4.0

PLOS ONE High rate of HSV-1 reactivation in invasively ventilated COVID-19 patients: Immunological findings
July 1, 2021 Jessica Seeßle, Theresa Hippchen, Paul Schnitzler, Julia Gsenger, Thomas Giese, Uta Merle

SARS-CoV-2 infection can lead to severe acute respiratory distress syndrome with the need of invasive ventilation. Pulmonary herpes…
Image credit
Fig 1. by Tsukanov et al., CC BY 4.0

PLOS ONE How risky is it to visit a supermarket during the pandemic?
July 1, 2021 Alexey A. Tsukanov, Alexandra M. Senjkevich, Maxim V. Fedorov, Nikolai V. Brilliantov

We performed large-scale numerical simulations using a composite model to investigate the infection spread in a supermarket during a…
Image credit
Fig 1. Reported indications for use of TCIM during COVID-19. by Lam et al., CC BY 4.0

PLOS ONE A public survey of traditional, complementary and integrative medicine use during the COVID-19 outbreak in Hong Kong
July 1, 2021 Chun Sing Lam, Ho Kee Koon, Vincent Chi-Ho Chung, Yin Ting Cheung

Background: During COVID-19, the public actively sought non-pharmacological and self-management approaches to prevent infection. Little is…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID/NIH, CC-0 Public Domain

PLOS ONE The impact of the SARS-COV2 infection on the disorder of consciousness rehabilitation unit
June 30, 2021 Silvia Marino, Rosella Ciurleo, Antonino Todaro, Antonella Alagna, Anna Lisa Logiudice, Francesco Corallo, Caterina Formica, Carmela Rifici, Patrizia Pollicino, Fabrizia Caminiti, Elisabetta Morini, Placido Bramanti

Background and objective: Disorders of consciousness include coma (cannot be aroused, eye remain closed), vegetative state—VS (can appear…
Image credit
Fig 2. Comparison of unadjusted trends in psychiatry consults between 2019 and 2020 cohorts. by McDowell et al., CC BY 4.0

PLOS ONE Evaluating the association between COVID-19 and psychiatric presentations, suicidal ideation in an emergency department
June 30, 2021 Michal J. McDowell, Carrie E. Fry, Mladen Nisavic, Mila Grossman, Charles Masaki, Emily Sorg, Suzanne Bird, Felicia Smith, Scott R. Beach

Objective: To estimate the association between COVID-19 and Emergency Department (ED) psychiatric presentations, including suicidal…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID/NIH, CC-0 Public Domain

PLOS ONE Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis
June 29, 2021 Ana Karla G. Melo, Keilla M. Milby, Ana Luiza M. A. Caparroz, Ana Carolina P. N. Pinto, Rodolfo R. P. Santos, Aline P. Rocha, Gilda A. Ferreira, Viviane A. Souza, Lilian D. A. Valadares, Rejane M. R. A. Vieira, Gecilmara S. Pileggi, Virgínia F. M. Trevisani

Objective: To describe the laboratory parameters and biomarkers of the cytokine storm syndrome associated with severe and fatal COVID-19…
Image credit
Fig 1. Timeline of the laboratory preparedness and response in the Americas Region to the COVID-19 outbreak, 31 December 2019 to 24 February 2020. by Leite et al., CC BY 4.0

PLOS ONE COVID-19 laboratory preparedness and response in the Americas Region: Lessons learned
June 29, 2021 Juliana Almeida Leite, Lionel Gresh, Andrea Vicari, Jean Marc Gabastou, Enrique Perez, Sylvain Aldighieri, SARINET laboratories Network , Jairo Mendez-Rico

By the time the etiologic agent of the COVID-19 was identified as a novel coronavirus, no country in the Americas Region had laboratory…
Image credit
Fig 1. Distribution of the SARS-CoV-2 antibody S/CO index measured by three chemiluminescence immunoassays according to days after onset. by Lee et al., CC BY 4.0

PLOS ONE Comparison of three serological chemiluminescence immunoassays for SARS-CoV-2, and clinical significance of antibody index with disease severity
June 29, 2021 Nuri Lee, Seri Jeong, Min-Jeong Park, Wonkeun Song

Background: The clinical significance of the quantitative value of antibodies in severe acute respiratory syndrome coronavirus 2…
Image credit
Fig 2. Primary study overlap matrix (percentage) across included systematic reviews*. by Ciapponi et al., CC BY 4.0

PLOS ONE COVID-19 and pregnancy: An umbrella review of clinical presentation, vertical transmission, and maternal and perinatal outcomes
June 29, 2021 Agustín Ciapponi, Ariel Bardach, Daniel Comandé, Mabel Berrueta, Fernando J. Argento, Federico Rodriguez Cairoli, Natalia Zamora, Victoria Santa María, Xu Xiong, Sabra Zaraa, Agustina Mazzoni, Pierre Buekens

Background: We conducted an overview of systematic reviews (SRs) summarizing the best evidence regarding the effect of COVID-19 on maternal…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, CC-0 Public Domain

PLOS ONE Neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, and eosinophils correlation with high-resolution computer tomography severity score in COVID-19 patients
June 28, 2021 Milena Adina Man, Ruxandra-Mioara Rajnoveanu, Nicoleta Stefania Motoc, Cosmina Ioana Bondor, Ana Florica Chis, Andrei Lesan, Ruxandra Puiu, Sergiu-Remus Lucaciu, Elena Dantes, Bianca Gergely-Domokos, Ovidiu Fira-Mladinescu

Inflammation has an important role in the progression of various viral pneumonia, including COVID-19. Circulating biomarkers that can…
Image credit
Fig 1. Pattern of worry scores of COVID-19 crisis by hospital. by Deressa et al., CC BY 4.0

PLOS ONE Risk perceptions and preventive practices of COVID-19 among healthcare professionals in public hospitals in Addis Ababa, Ethiopia
June 25, 2021 Wakgari Deressa, Alemayehu Worku, Workeabeba Abebe, Muluken Gizaw, Wondwossen Amogne

Healthcare professionals are at higher risk of contracting the new coronavirus disease 2019 (COVID-19). Although appropriate preventive…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID, CC-0 Public Domain

PLOS ONE Impact of Covid-19 on attendances for a 1^st episode of reduced fetal movements: A retrospective observational study
June 25, 2021 Laia Marques-Fernandez, Swati Sharma, Una Mannu, Hsu Phern Chong

Background: Prior studies have demonstrated an increased stillbirth rate. It was suggested that the COVID-19 pandemic may have impacted on…
Image credit
Fig 1. Mortality rates over time in adults with COVID-19 and acute respiratory distress syndrome or acute respiratory failure. by Yeates et al., CC BY 4.0

PLOS ONE Improved outcomes over time for adult COVID-19 patients with acute respiratory distress syndrome or acute respiratory failure
June 25, 2021 Eric O. Yeates, Jeffry Nahmias, Justine Chinn, Brittany Sullivan, Stephen Stopenski, Alpesh N. Amin, Ninh T. Nguyen

Background: COVID-19’s pulmonary manifestations are broad, ranging from pneumonia with no supplemental oxygen requirements to acute…
Image credit
Fig 1. by Deol et al., CC BY 4.0

PLOS ONE Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens
June 24, 2021 Arminder K. Deol, Danny Scarponi, Peter Beckwith, Tom A. Yates, Aaron S. Karat, Ada W. C. Yan, Kathy S. Baisley, Alison D. Grant, Richard G. White, Nicky McCreesh

Background: In light of the role that airborne transmission plays in the spread of SARS-CoV-2, as well as the ongoing high global mortality…
Image credit
Syringe and Vaccine by NIH/NIAID, CC BY 2.0

PLOS ONE Determinant of intention to receive COVID-19 vaccine among school teachers in Gondar City, Northwest Ethiopia
June 24, 2021 Simegnew Handebo, Maereg Wolde, Kegnie Shitu, Ayenew Kassie

Background: Scientists across the world are working on innovating a successful vaccine that will save lives and end COVID-19 pandemic.…
Image credit
Fig 3. Statin use, after hospitalization. by Chow et al., CC BY 4.0

PLOS ONE The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis
June 24, 2021 Ronald Chow, James Im, Nicholas Chiu, Leonard Chiu, Rahul Aggarwal, Jihui Lee, Young-Geun Choi, Elizabeth Horn Prsic, Hyun Joon Shin

Introduction: Statins may reduce a cytokine storm, which has been hypothesized as a possible mechanism of severe COVID-19 pneumonia. The…
Image credit
Fig 1. Histogram of intervals between estimated origin dates and first cases (Origin) and between upper bounds of 95% confidence intervals and first cases (95% CI). by Roberts et al., CC BY 4.0

PLOS Pathogens Dating first cases of COVID-19
June 24, 2021 David L. Roberts, Jeremy S. Rossman, Ivan Jarić

Questions persist as to the origin of the COVID-19 pandemic. Evidence is building that its origin as a zoonotic spillover occurred prior…
Image credit
Fig 1. Correlation heatmap between self-defined ethnicities and pre-existing conditions. by Cavallaro et al., CC BY 4.0

PLOS Computational Biology Contrasting factors associated with COVID-19-related ICU admission and death outcomes in hospitalised patients by means of Shapley values
June 23, 2021 Massimo Cavallaro, Haseeb Moiz, Matt J. Keeling, Noel D. McCarthy

Identification of those at greatest risk of death due to the substantial threat of COVID-19 can benefit from novel approaches to…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, CC-0 Public Domain

PLOS ONE COVID-19 pneumonia in Galicia (Spain): Impact of prognostic factors and therapies on mortality and need for mechanical ventilation
June 23, 2021 Luis Pérez-de-Llano, Eva María Romay-Lema, Adolfo Baloira-Villar, Christian Anchorena, María Luisa Torres-Durán, Adrián Sousa, Dolores Corbacho-Abelaira, José Paz-Ferrin, Carmen Diego-Roza, Laura Vilariño-Maneiro, Pedro J. Marcos, Carmen Montero-Martínez, Fernando de la Iglesia-Martínez, Vanessa Riveiro-Blanco, Nuria Rodríguez-Núñez, José Abal-Arca, María Bustillo-Casado, Rafael Golpe

Introduction: This study was aimed to identify risk factors associated with unfavorable outcomes (composite outcome variable: mortality and…
Image credit
Fig 2. Map of national seroprevalence studies reporting population-wide estimates. by Natural Earth and Bobrovitz et al., CC BY 4.0

PLOS ONE Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis
June 23, 2021 Niklas Bobrovitz, Rahul Krishan Arora, Christian Cao, Emily Boucher, Michael Liu, Claire Donnici, Mercedes Yanes-Lane, Mairead Whelan, Sara Perlman-Arrow, Judy Chen, Hannah Rahim, Natasha Ilincic, Mitchell Segal, Nathan Duarte, Jordan Van Wyk, Tingting Yan, Austin Atmaja, Simona Rocco, Abel Joseph, Lucas Penny, David A. Clifton, Tyler Williamson, Cedric P. Yansouni, Timothy Grant Evans, Jonathan Chevrier, Jesse Papenburg, Matthew P. Cheng

Background: Many studies report the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies. We aimed to…
Image credit
Fig 1. Odds ratios for critical and fatal illness according to body mass index. by Kang and Kong, CC BY 4.0

PLOS ONE Body mass index and severity/fatality from coronavirus disease 2019: A nationwide epidemiological study in Korea
June 22, 2021 In Sook Kang, Kyoung Ae Kong

Objective: Obesity has been reported as a risk factor for severe coronavirus disease 2019 (COVID-19) in recent studies. However, the…
Image credit
Novel Coronavirus SARS-Cov-2 by NIAID, CC-0 Public Domain

PLOS ONE Blood coagulation parameter abnormalities in hospitalized patients with confirmed COVID-19 in Ethiopia
June 21, 2021 Shambel Araya, Mintesnot Aragaw Mamo, Yakob Gebregziabher Tsegay, Asegdew Atlaw, Aschalew Aytenew, Abebe Hordofa, Abebe Edao Negeso, Moges Wordofa, Tirhas Niguse, Mahlet Cheru, Zemenu Tamir

Background: Coagulopathy and thromboembolic events are among the complications of Corona Virus disease 2019 (COVID-19). Abnormal…
Image credit
Fig 1. Logistic growth curve of the COVID-19 pandemic. by Kaimann and Tanneberg, CC BY 4.0

PLOS ONE What containment strategy leads us through the pandemic crisis? An empirical analysis of the measures against the COVID-19 pandemic
June 21, 2021 Daniel Kaimann, Ilka Tanneberg

Since January 2020, the COVID-19 outbreak has been progressing at a rapid pace. To keep the pandemic at bay, countries have implemented…
Image credit
3D-printed physical model of SARS-CoV-2 by NIH, CC-0 Public Domain

PLOS ONE Predictors of severity and mortality among patients hospitalized with COVID-19 in Rhode Island
June 18, 2021 Aakriti Pandita, Fizza S. Gillani, Yiyun Shi, Anna Hardesty, Meghan McCarthy, Jad Aridi, Dimitrios Farmakiotis, Silvia S. Chiang, Curt G. Beckwith

Background: In order for healthcare systems to prepare for future waves of COVID-19, an in-depth understanding of clinical predictors is…
Image credit
Fig 2. The position of the simulation box, native ligand, and cluster of spheres relative to the receptor. by Purwati et al., CC BY 4.0

PLOS ONE An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia
June 18, 2021 Purwati, Andang Miatmoko, Nasronudin, Eryk Hendrianto, Deya Karsari, Aristika Dinaryanti, Nora Ertanti, Igo Syaiful Ihsan, Disca Sandyakala Purnama, Tri Pudy Asmarawati, Erika Marfiani, Yulistiani, Alfian Nur Rosyid, Prastuti Asta Wulaningrum, Herley Windo Setiawan, Imam Siswanto, Ni Nyoman Tri Puspaningsih

A potent therapy for the infectious coronavirus disease COVID-19 is urgently required with, at the time of writing, research in this area…
Image credit
Fig 3. Scatterplot of the incidence rate of tuberculosis (TB) in 1990 versus (a) the cumulative mortality rate of COVID-19 and (b) the cumulative incidence rate of COVID-19 on 5 April 2020 according to BCG vaccination status among 90 countries. by Inoue and Kashima, CC BY 4.0

PLOS ONE Association of the past epidemic of Mycobacterium tuberculosis with mortality and incidence of COVID-19
June 18, 2021 Kazuo Inoue, Saori Kashima

The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has created…
Image credit
Fig 1. Culminating measures model for the general population. by Shumway et al., CC BY 4.0

PLOS ONE Predictors of compliance with COVID-19 related non-pharmaceutical interventions among university students in the United States
June 18, 2021 Spencer G. Shumway, Jonas D. Hopper, Ethan R. Tolman, Daniel G. Ferguson, Gabriella Hubble, David Patterson, Jamie L. Jensen

The world is currently dealing with a devastating pandemic. Although growing COVID-19 case numbers, deaths, and hospitalizations are…
Image credit
Fig 3. Care needs of previously self-care patients after inpatient treatment of COVID-19 (n = 59). by Herrmann et al., CC BY 4.0

PLOS ONE COVID-19 in persons aged 70+ in an early affected German district: Risk factors, mortality and post-COVID care needs—A retrospective observational study of hospitalized and non-hospitalized patients
June 18, 2021 Matthias L. Herrmann, Johannes-Martin Hahn, Birgit Walter-Frank, Desiree M. Bollinger, Kristina Schmauder, Günter Schnauder, Michael Bitzer, Nisar P. Malek, Gerhard W. Eschweiler, Siri Göpel

Background: Cohorts of hospitalized COVID-19 patients have been studied in several countries since the beginning of the pandemic. So far,…
Image credit
Fig 3. Cumulative weekly case counts from March 1 to May 16, 2020 for the United States, New York, Washington, and Louisiana, as estimated by each method and the reported cases. by Lu et al., CC BY 4.0

PLOS Computational Biology Estimating the cumulative incidence of COVID-19 in the United States using influenza surveillance, virologic testing, and mortality data: Four complementary approaches
June 17, 2021 Fred S. Lu, Andre T. Nguyen, Nicholas B. Link, Mathieu Molina, Jessica T. Davis, Matteo Chinazzi, Xinyue Xiong, Alessandro Vespignani, Marc Lipsitch, Mauricio Santillana

Effectively designing and evaluating public health responses to the ongoing COVID-19 pandemic requires accurate estimation of the…
Image credit
Fig 1. Pathogen reproductive number, R_t, plotted against the ratio of contacts needing tracing to contact tracing capacity for variable delays (1/τ_Is) of 1–5 and 10 days between case symptom onset and the start of contact tracing (including getting tested and receiving result). by Gardner and Kilpatrick, CC BY 4.0

PLOS Computational Biology Contact tracing efficiency, transmission heterogeneity, and accelerating COVID-19 epidemics
June 17, 2021 Billy J. Gardner, A. Marm Kilpatrick

Simultaneously controlling COVID-19 epidemics and limiting economic and societal impacts presents a difficult challenge, especially with…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases/NIH, CC-0 Public Domain

PLOS ONE Post-infectious and post-acute sequelae of critically ill adults with COVID-19
June 17, 2021 Halah Ibrahim, Syed Athar, Thana Harhara, Shahad Abasaeed Elhag, Salma MElnour, Hoor H. Sukkar, Ashraf M. Kamour

Background: Data on the post-acute and post-infectious complications of patients who have recovered from severe coronavirus disease 2019…
Image credit
Fig 2. Heat map of symptomatic and sample of asymptomatic patients displaying time of enrollment, survey completion, time of symptom development, and follow-up. by Marcus et al., CC BY 4.0

PLOS ONE Predictors of incident viral symptoms ascertained in the era of COVID-19
June 17, 2021 Gregory M. Marcus, Jeffrey E. Olgin, Noah D. Peyser, Eric Vittinghoff, Vivian Yang, Sean Joyce, Robert Avram, Geoffrey H. Tison, David Wen, Xochitl Butcher, Helena Eitel, Mark J. Pletcher

Background: In the absence of universal testing, effective therapies, or vaccines, identifying risk factors for viral infection,…
Image credit
Fig 2. Antibody titers (AU/mL) classified by age group, gender and region of residence of donors. by Muttamba et al., CC BY 4.0

PLOS ONE Feasibility of collecting and processing of COVID-19 convalescent plasma for treatment of COVID-19 in Uganda
June 17, 2021 Winters Muttamba, John Lusiba, Loryndah Olive Namakula, Pauline Byakika-Kibwika, Francis Ssali, Henry Ddungu, Levicatus Mugenyi, Noah Kiwanuka, Rogers Sekibira, Cissy Kityo, Dorothy Keyune, Susan Acana, Ambrose Musinguzi, Ayub Masasi, Joseph Byamugisha, David Mpanju, Walter Jack Musoki, Hellen Aanyu Tukamuhebwa, Fred Nakwagala, Bernard Sentalo Bagaya, Alex Kayongo, Ivan Kimuli, Rebecca Nantanda, Winceslaus Katagira, Esther Buregyeya, Rosemary Byanyima, Baterana Byarugaba, Trishul Siddharthan, Henry Mwebesa, Olaro Charles, Moses Lutaakome Joloba, William Bazeyo, Bruce Kirenga

Introduction: Evidence that supports the use of COVID-19 convalescent plasma (CCP) for treatment of COVID-19 is increasingly emerging.…
Image credit
Fig 1. Histograms and smoothed density plots of the documented shedding (blue) and documented resolution (red) distributions. by Phillips et al., CC BY 4.0

PLOS ONE Duration of SARS-CoV-2 shedding: A population-based, Canadian study
June 17, 2021 Susan P. Phillips, Xuejiao Wei, Jeffrey C. Kwong, Jonathan Gubbay, Kevin L. Schwartz, Anna Majury, Patti A. Groome

Introduction: There is an evidence gap regarding the duration of SARS-CoV-2 shedding and of its variability across different care settings…
Image credit
Fig 1. Patient distribution of the 4704 included patients in Germany. by Gessler et al., CC BY 4.0

PLOS ONE Clinical outcome, risk assessment, and seasonal variation in hospitalized COVID-19 patients—Results from the CORONA Germany study
June 17, 2021 Nele Gessler, Melanie A. Gunawardene, Peter Wohlmuth, Dirk Arnold, Juergen Behr, Christian Gloeckner, Klaus Herrlinger, Thomas Hoelting, Ulrich-Frank Pape, Ruediger Schreiber, Axel Stang, Claas Wesseler, Stephan Willems, Charlotte Arms, Christoph U. Herborn

Background: After one year of the pandemic and hints of seasonal patterns, temporal variations of in-hospital mortality in COVID-19 are…
Image credit
Fig 1. Crude and directly standardized mortality rates in Switzerland for the period 1970–2020 (data from the Swiss Federal Statistical Office and the Human Mortality Database). by Locatelli and Rousson, CC BY 4.0

PLOS ONE A first analysis of excess mortality in Switzerland in 2020
June 17, 2021 Isabella Locatelli, Valentin Rousson

Objective: To quantify excess all-cause mortality in Switzerland in 2020, a key indicator for assessing direct and indirect consequences of…
Image credit
Fig 1. Axial Computed Tomography images of a 59 years-old male affected by COVID-19, hospitalized in a COVID-19 ward, demonstrating the applied method of measurements of muscle densitometry. by Giraudo et al., CC BY 4.0

PLOS ONE Reduced muscle mass as predictor of intensive care unit hospitalization in COVID-19 patients
June 17, 2021 Chiara Giraudo, Giovanni Librizzi, Giulia Fichera, Raffaella Motta, Elisabetta Balestro, Fiorella Calabrese, Giovanni Carretta, Anna Maria Cattelan, Paolo Navalesi, Michela Pelloso, Mario Plebani, Federico Rea, Roberto Vettor, Andrea Vianello, Roberto Stramare

Purpose: To evaluate if reduced muscle mass, assessed with Computed Tomography (CT), is a predictor of intensive care unit (ICU)…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases/NIH, CC-0 Public Domain

PLOS ONE Reported health and social consequences of the COVID-19 pandemic on vulnerable populations and implemented solutions in six West African countries: A media content analysis
June 16, 2021 Khalida Saalim, Kwame S. Sakyi, Fatema-Tuz-Zohra, Emily Morrison, Prince Owusu, Sarah L. Dalglish, Mufaro Kanyangarara

Coronavirus has spread worldwide with over 140 million cases and resulting in more than 3 million deaths between November 2019 to April…
Image credit
Fig 2. Forest plot of the prevalence of COVID-19 in ESRD patients with RRT. by Nopsopon et al., CC BY 4.0

PLOS Neglected Tropical Diseases Covid-19 in end-stage renal disease patients with renal replacement therapies: A systematic review and meta-analysis
June 15, 2021 Tanawin Nopsopon, Jathurong Kittrakulrat, Kullaya Takkavatakarn, Thanee Eiamsitrakoon, Talerngsak Kanjanabuch, Krit Pongpirul

Background: The novel coronavirus (COVID-19), caused by SARS-CoV-2, showed various prevalence and case-fatality rates (CFR) among patients…
Image credit
Fig 1. Comparison of clinic characteristics of COVID-19 patients in Mild-Moderate and Severe-Critically Severe groups (n = 196). by Luo et al., CC BY 4.0

PLOS ONE The selection of indicators from initial blood routine test results to improve the accuracy of early prediction of COVID-19 severity
June 15, 2021 Jiaqing Luo, Lingyun Zhou, Yunyu Feng, Bo Li, Shujin Guo

The global pandemic of COVID-19 poses a huge threat to the health and lives of people all over the world, and brings unprecedented…
Image credit
Fig 1. Sex and age-stratified COVID-19 incidence estimates by region (A, B and C), Peru, 2020. by Ramírez-Soto et al., CC BY 4.0

PLOS ONE Sex differences in the incidence, mortality, and fatality of COVID-19 in Peru
June 14, 2021 Max Carlos Ramírez-Soto, Hugo Arroyo-Hernández, Gutia Ortega-Cáceres

Background: There is a worrying lack of epidemiological data on the sex differential in COVID-19 infection and death rates between the…
Image credit
Fig 1. by Borse et al., CC BY 4.0

PLOS ONE Ayurveda botanicals in COVID-19 management: An in silico multi-target approach
June 11, 2021 Swapnil Borse, Manali Joshi, Akash Saggam, Vedika Bhat, Safal Walia, Aniket Marathe, Sneha Sagar, Preeti Chavan-Gautam, Aboli Girme, Lal Hingorani, Girish Tillu

The Coronavirus disease (COVID-19) caused by the virus SARS-CoV-2 has become a global pandemic in a very short time span. Currently, there…
Image credit
Fig 1. Mortality Trends in COVID-19 admissions. by Coppock et al., CC BY 4.0

PLOS ONE COVID-19 treatment combinations and associations with mortality in a large multi-site healthcare system
June 11, 2021 Dagan Coppock, Michael Baram, Anna Marie Chang, Patricia Henwood, Alan Kubey, Ross Summer, John Zurlo, Michael Li, Bryan Hess

Introduction: During the early months of the COVID-19 pandemic, mortality associated with the disease declined in the United States. The…
Image credit
Fig 3. IgG levels in the patients during the three visits. by Alzaabi et al., CC BY 4.0

PLOS ONE Longitudinal changes in IgG levels among COVID-19 recovered patients: A prospective cohort study
June 11, 2021 Ashraf Hassan Alzaabi, Luai A. Ahmed, Abdulla E. Rabooy, Ali Al Zaabi, Mohammed Alkaabi, Falah AlMahmoud, Mai Farouk Hamed, Khalid Omar Bashaeb, Abdul Rahim Bakhsh, Suha Adil, Nadeen Elmajed, Ahmed Nigm Abousalha, Ahmad Kanaan Uwaydah, Khulood Al Mazrouei

Objectives: To quantify SARS-CoV2 IgG antibody titers over time and assess the longevity of the immune response in a multi-ethnic…
Image credit
Fig 1. Stability of SARS-CoV-2 RNA in a swab of saliva mixed with eNAT (A) or saliva diluted 1:2 with eNAT (B). by Banik et al., CC BY 4.0

PLOS ONE Inactivation of SARS-CoV-2 virus in saliva using a guanidium based transport medium suitable for RT-PCR diagnostic assays
June 11, 2021 Sukalyani Banik, Kaheerman Saibire, Shraddha Suryavanshi, Glenn Johns, Soumitesh Chakravorty, Robert Kwiatkowski, David Alland, Padmapriya P. Banada

Background: Upper respiratory samples used to test for SARS-CoV-2 virus may be infectious and present a hazard during transport and…
Image credit
Fig 1. by Fowler et al., CC BY 4.0

PLOS ONE Stay-at-home orders associate with subsequent decreases in COVID-19 cases and fatalities in the United States
June 10, 2021 James H. Fowler, Seth J. Hill, Remy Levin, Nick Obradovich

Governments issue “stay-at-home” orders to reduce the spread of contagious diseases, but the magnitude of such orders’ effectiveness…
Image credit
Fig 1. Different slices of CT scans representing each patients group. by Alves et al., CC BY 4.0

PLOS ONE Automatic algorithm for quantifying lung involvement in patients with chronic obstructive pulmonary disease, infection with SARS-CoV-2, paracoccidioidomycosis and no lung disease patients
June 10, 2021 Allan Felipe Fattori Alves, José Ricardo Arruda Miranda, Fabiano Reis, Abner Alves Oliveira, Sérgio Augusto Santana Souza, Carlos Magno Castelo Branco Fortaleza, Suzana Erico Tanni, José Thiago Souza Castro, Diana Rodrigues Pina

In this work, we aimed to develop an automatic algorithm for the quantification of total volume and lung impairments in four different…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases/NIH, CC-0 Public Domain

PLOS ONE Nurses’ core disaster-response competencies for combating COVID-19—A cross-sectional study
June 10, 2021 Igor Karnjuš, Mirko Prosen, Sabina Ličen

The core competencies in disaster nursing, nurses’ roles in disaster management and the potential barriers are assessed with a view to…
Image credit
Fig 1. Stay-at-home measure and number of new infections, Tokyo. by Watanabe and Yabu, CC BY 4.0

PLOS ONE Japan’s voluntary lockdown
June 10, 2021 Tsutomu Watanabe, Tomoyoshi Yabu

Japan’s government has taken a number of measures, including declaring a state of emergency, to combat the spread COVID-19. We examine the…
Image credit
Fig 1. Differences between German and Austrian GPs in their evaluation of the pandemic (Austria: n = 900; Germany: n = 1287). by Siebenhofer et al., CC BY 4.0

PLOS ONE COVI-Prim survey: Challenges for Austrian and German general practitioners during initial phase of COVID-19
June 10, 2021 Andrea Siebenhofer, Sebastian Huter, Alexander Avian, Karola Mergenthal, Dagmar Schaffler-Schaden, Ulrike Spary-Kainz, Herbert Bachler, Maria Flamm

Background: Coronavirus disease 2019 (COVID-19) represents a significant challenge to health care systems around the world. A…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases/NIH, CC-0 Public Domain

PLOS ONE Low level SARS-CoV-2 RNA detected in plasma samples from a cohort of Nigerians: Implications for blood transfusion
June 10, 2021 Azuka Patrick Okwuraiwe, Chika Kingsley Onwuamah, Joseph Ojonugwa Shaibu, Samuel Olufemi Amoo, Fehintola Anthonia Ige, Ayorinde Babatunde James, Leona Chika Okoli, Abul-Rahman Ahmed, Jamda Ponmak, Judith O. Sokei, Sulaimon Akanmu, Babatunde Lawal Salako, Rosemary Ajuma Audu

The present global pandemic triggered by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has lingered for over a year in…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases/NIH, CC-0 Public Domain

PLOS ONE Investigation of superspreading COVID-19 outbreak events in meat and poultry processing plants in Germany: A cross-sectional study
June 10, 2021 Roman Pokora, Susan Kutschbach, Matthias Weigl, Detlef Braun, Annegret Epple, Eva Lorenz, Stefan Grund, Juergen Hecht, Helmut Hollich, Peter Rietschel, Frank Schneider, Roland Sohmen, Katherine Taylor, Isabel Dienstbuehl

Since May 2020, several COVID-19 outbreaks have occurred in the German meat industry despite various protective measures, and temperature…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID/NIH, CC-0 Public Domain

PLOS ONE Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States
June 10, 2021 Lilah Lopez, Thao Nguyen, Graham Weber, Katlyn Kleimola, Megan Bereda, Yiling Liu, Emma K. Accorsi, Steven J. Skates, John P. Santa Maria Jr., Kendal R. Smith, Mark Kalinich

Since March 2020, the United States has lost over 580,000 lives to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which…
Image credit
Fig 1. Viability of SARS-CoV-2 on stainless steel after exposure to simulated sunlight. by Sloan et al., CC BY 4.0

PLOS ONE Simulated sunlight decreases the viability of SARS-CoV-2 in mucus
June 10, 2021 Angela Sloan, Todd Cutts, Bryan D. Griffin, Samantha Kasloff, Zachary Schiffman, Mable Chan, Jonathan Audet, Anders Leung, Darwyn Kobasa, Derek R. Stein, David Safronetz, Guillaume Poliquin

The novel coronavirus, SARS-CoV-2, has spread into a pandemic since its emergence in Wuhan, China in December of 2019. This has been…
Image credit
Fig 1. Variability in SARS-CoV-2 IgG antibody response. by Schaefer et al., CC BY 4.0

PLOS ONE Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging
June 10, 2021 Ernst J. Schaefer, Latha Dulipsingh, Florence Comite, Jessica Jimison, Martin M. Grajower, Nathan E. Lebowitz, Maxine Lang, Andrew S. Geller, Margaret R. Diffenderfer, Lihong He, Gary Breton, Michael L. Dansinger, Ben Saida, Chong Yuan

Most deaths from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection occur in older subjects. We assessed the utility…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID/NIH, CC-0 Public Domain

PLOS ONE Screening for SARS-CoV-2 by RT-PCR: Saliva or nasopharyngeal swab? Rapid review and meta-analysis
June 10, 2021 Nusaïbah Ibrahimi, Agnès Delaunay-Moisan, Catherine Hill, Gwénaël Le Teuff, Jean-François Rupprecht, Jean-Yves Thuret, Dan Chaltiel, Marie-Claude Potier

Background: Diagnosis of COVID-19 in symptomatic patients and screening of populations for SARS-CoV-2 infection require access to…
Image credit
Fig 1. Treatment outcome among patients admitted with COVID-19 in WURH treatment. by Tolossa et al., CC BY 4.0

PLOS ONE Time to recovery from COVID-19 and its predictors among patients admitted to treatment center of Wollega University Referral Hospital (WURH), Western Ethiopia: Survival analysis of retrospective cohort study
June 10, 2021 Tadesse Tolossa, Bizuneh Wakuma, Dejene Seyoum Gebre, Emiru Merdassa Atomssa, Motuma Getachew, Getahun Fetensa, Diriba Ayala, Ebisa Turi

Introduction: Despite its alarming spread throughout the world, no effective drug and vaccine is discovered for COVID-19 so far. According…
Image credit
Fig 1. Distribution of treatment modalities over time. by Malhani et al., CC BY 4.0

PLOS ONE Combination of (interferon beta-1b, lopinavir/ritonavir and ribavirin) versus favipiravir in hospitalized patients with non-critical COVID-19: A cohort study
June 10, 2021 Areej A. Malhani, Mushira A. Enani, Fatemeh Saheb Sharif-Askari, Mona R. Alghareeb, Roaa T. Bin-Brikan, Safar A. AlShahrani, Rabih Halwani, Imad M. Tleyjeh

Objectives: Our study aims at comparing the efficacy and safety of IFN-based therapy (lopinavir/ritonavir, ribavirin, and interferon β-1b)…
Image credit
Fig 1. Racial discrepancies between NMH 2019 kidney transplant recipients and the SARS-CoV 2 positive kidney transplant recipient cohort. by Nahi et al., CC BY 4.0

PLOS ONE Renal allograft function in kidney transplant recipients infected with SARS-CoV 2: An academic single center experience
June 10, 2021 Skylar L. Nahi, Aneesha A. Shetty, Sajal D. Tanna, Joseph R. Leventhal

Background: Kidney transplant recipients are a unique cohort in regard to SARS-CoV 2 susceptibility and clinical course, owing to their…
Image credit
Fig 1. The numbers of matched nasopharyngeal and saliva samples. by Ota et al., CC BY 4.0

PLOS ONE Detection of SARS-CoV-2 using qRT-PCR in saliva obtained from asymptomatic or mild COVID-19 patients, comparative analysis with matched nasopharyngeal samples
June 10, 2021 Kenji Ota, Katsunori Yanagihara, Daisuke Sasaki, Norihito Kaku, Naoki Uno, Kei Sakamoto, Kosuke Kosai, Taiga Miyazaki, Hiroo Hasegawa, Ayumi Fujita, Masato Tashiro, Takeshi Tanaka, Koichi Izumikawa, Koya Ariyoshi, Hiroshi Mukae, Jiro Yasuda, Kouichi Morita, Shigeru Kohno

Objectives: The accurate detection of severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) is essential for the diagnosis of…
Image credit
Fig 3. Survival curves, regarding the primary outcome, comparing HCQ/AZI and control group. by Saib et al., CC BY 4.0

PLOS ONE Lack of efficacy of hydroxychloroquine and azithromycin in patients hospitalized for COVID-19 pneumonia: A retrospective study
June 9, 2021 Anis Saib, Walid Amara, Pascal Wang, Simon Cattan, Azeddine Dellal, Kais Regaieg, Stephane Nahon, Olivier Nallet, Lee S. Nguyen

Background: Hydroxychloroquine combined with azithromycin (HCQ/AZI) has initially been used against coronavirus disease-2019 (COVID-19). In…
Image credit
Fig 1. Generation of SARS-CoV2-SP-pseudotyped lentivirus particles (SCoV-2-SP-PVs). by Ao et al., CC BY 4.0

PLOS ONE Identification and evaluation of the inhibitory effect of Prunella vulgaris extract on SARS-coronavirus 2 virus entry
June 9, 2021 Zhujun Ao, Mable Chan, Maggie Jing Ouyang, Titus Abiola Olukitibi, Mona Mahmoudi, Darwyn Kobasa, Xiaojian Yao

Until now, antiviral therapeutic agents are still urgently required for treatment or prevention of SARS-coronavirus 2 (SCoV-2) virus…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID/NIH, CC-0 Public Domain

PLOS ONE Influence of thromboembolic events in the prognosis of COVID-19 hospitalized patients. Results from a cross sectional study
June 9, 2021 Francisco Purroy, Gloria Arqué

Background: COVID-19 may predispose to both venous and arterial thromboembolism event (TEE). Reports on the prevalence and prognosis of…
Image credit
Fig 2. Estimated basic reproduction numbers (R₀) for countries across the globe. by Kong et al., CC BY 4.0

PLOS ONE Social, economic, and environmental factors influencing the basic reproduction number of COVID-19 across countries
June 9, 2021 Jude Dzevela Kong, Edward W. Tekwa, Sarah A. Gignoux-Wolfsohn

Objective: To assess whether the basic reproduction number (R0) of COVID-19 is different across countries and what national-level…
Image credit
Fig 2. by Poschenrieder et al., CC BY 4.0

PLOS ONE Severe COVID-19 pneumonia: Perfusion analysis in correlation with pulmonary embolism and vessel enlargement using dual-energy CT data
June 8, 2021 Florian Poschenrieder, Stefanie Meiler, Matthias Lubnow, Florian Zeman, Janine Rennert, Gregor Scharf, Jan Schaible, Christian Stroszczynski, Michael Pfeifer, Okka W. Hamer

Background: Gas exchange in COVID-19 pneumonia is impaired and vessel obstruction has been suspected to cause ventilation-perfusion…
Image credit
Fig 1. The global model collects local models updates. by Abdul Salam et al., CC BY 4.0

PLOS ONE COVID-19 detection using federated machine learning
June 8, 2021 Mustafa Abdul Salam, Sanaa Taha, Mohamed Ramadan

The current COVID-19 pandemic threatens human life, health, and productivity. AI plays an essential role in COVID-19 case classification…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, CC-0 Public Domain

PLOS ONE Excess mortality by specific causes of deaths in the city of São Paulo, Brazil, during the COVID-19 pandemic
June 7, 2021 Gisele Aparecida Fernandes, Antonio Paulo Nassar Junior, Gulnar Azevedo e Silva, Diego Feriani, Ivan Leonardo Avelino França e Silva, Pedro Caruso, Maria Paula Curado

Background: To investigate the excess of deaths by specific causes, in the first half of 2020 in the city of São Paulo-Brazil, during the…
Image credit
Fig 3. Representative case without COVID-19 pneumonia. by Hwang et al., CC BY 4.0

PLOS ONE COVID-19 pneumonia on chest X-rays: Performance of a deep learning-based computer-aided detection system
June 7, 2021 Eui Jin Hwang, Ki Beom Kim, Jin Young Kim, Jae-Kwang Lim, Ju Gang Nam, Hyewon Choi, Hyungjin Kim, Soon Ho Yoon, Jin Mo Goo, Chang Min Park

Chest X-rays (CXRs) can help triage for Coronavirus disease (COVID-19) patients in resource-constrained environments, and a computer-aided…
Image credit
Fig 2. Timeline of SARS-CoV-2 R.1 lineage emergence and country-specific percentages of global cases. by Hirotsu and Omata, CC BY 4.0

PLOS Pathogens Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan
June 7, 2021 Yosuke Hirotsu, Masao Omata

We aimed to investigate novel emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages in Japan that harbor variants…
Image credit
Fig 2. Marginal effects of temperature (t-14) on Covid-19 fatalities (direct effect with DFE estimates). by Damette et al., CC BY 4.0

PLOS ONE Meteorological factors against COVID-19 and the role of human mobility
June 4, 2021 Olivier Damette, Clément Mathonnat, Stéphane Goutte

In the vein of recent empirical literature, we reassessed the impact of weather factors on Covid-19 daily cases and fatalities in a panel…
Image credit
Fig 1. Relative excess mortality among Californians 18–65 years of age, March through November 2020. by Chen et al., CC BY 4.0

PLOS ONE Excess mortality associated with the COVID-19 pandemic among Californians 18–65 years of age, by occupational sector and occupation: March through November 2020
June 4, 2021 Yea-Hung Chen, Maria Glymour, Alicia Riley, John Balmes, Kate Duchowny, Robert Harrison, Ellicott Matthay, Kirsten Bibbins-Domingo

Background: Though SARS-CoV-2 outbreaks have been documented in occupational settings and in-person essential work has been suspected as a…
Image credit
Fig 2. Proportions of pooling of secretions and recommendations of oral intake in COVID-19 patients treated in the ICU at the time of the first FEES examination. by Osbeck Sandblom et al., CC BY 4.0

PLOS ONE Characterization of dysphagia and laryngeal findings in COVID-19 patients treated in the ICU—An observational clinical study
June 4, 2021 Hanna Osbeck Sandblom, Hans Dotevall, Kristina Svennerholm, Lisa Tuomi, Caterina Finizia

Background: Dysphagia appears to be common in patients with severe COVID-19. Information about the characteristics of dysphagia and…
Image credit
Fig 2. Day 0 plasma ACE2 in COVID-19 positive patients by clinical outcome group and ROC curve. by Kragstrup et al., CC BY 4.0

PLOS ONE Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients
June 4, 2021 Tue W. Kragstrup, Helene Søgaard Singh, Ida Grundberg, Ane Langkilde-Lauesen Nielsen, Felice Rivellese, Arnav Mehta, Marcia B. Goldberg, Michael R. Filbin, Per Qvist, Bo Martin Bibby

Aims: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to angiotensin converting enzyme 2 (ACE2) enabling entrance of the…
Image credit
sadness by Georgie Pauwels, CC BY 2.0

PLOS ONE Assessment of depressive symptoms in patients with COVID-19 during the second wave of epidemic in Myanmar: A cross-sectional single-center study
June 4, 2021 Ye Minn Htun, Kyaw Thiha, Aung Aung, Nay Myo Aung, Thet Wai Oo, Pyae Sone Win, Nay Hein Sint, Kaung Myat Naing, Aung Khant Min, Kyaw Myo Tun, Kyaw Hlaing

Background: Coronavirus disease 2019 (COVID-19) pandemic has had a great impact on every aspect of society. All countries launched…
Image credit
Fig 1. Baseline and highest or lowest values for selected laboratory values in ESKD and non-ESKD groups. by Kamel et al., CC BY 4.0

PLOS ONE End-stage kidney disease and COVID-19 in an urban safety-net hospital in Boston, Massachusetts
June 4, 2021 Mohamed Hassan Kamel, Hassan Mahmoud, Aileen Zhen, Jing Liu, Catherine G. Bielick, Anahita Mostaghim, Nina Lin, Vipul Chitalia, Titilayo Ilori, Sushrut S. Waikar, Ashish Upadhyay

Introduction: End-stage kidney disease (ESKD) patients are at a high risk for Coronavirus Disease 2019 (COVID-19). In this study, we…
Image credit
Fig 1. Schematic diagram of the contact tracing model. by James et al., CC BY 4.0

PLOS ONE Successful contact tracing systems for COVID-19 rely on effective quarantine and isolation
June 3, 2021 A. James, M. J. Plank, S. Hendy, R. Binny, A. Lustig, N. Steyn, A. Nesdale, A. Verrall

Models of contact tracing often over-simplify the effects of quarantine and isolation on disease transmission. We develop a model that…
Image credit
Fig 1. Data extraction and processing. by Tortolero et al., CC BY 4.0

PLOS ONE Leveraging a health information exchange for analyses of COVID-19 outcomes including an example application using smoking history and mortality
June 3, 2021 Guillermo A. Tortolero, Michael R. Brown, Shreela V. Sharma, Marcia C. de Oliveira Otto, Jose-Miguel Yamal, David Aguilar, Matt D. Gunther, Dania I. Mofleh, Rachel D. Harris, Jemima C. John, Paul S. de Vries, Ryan Ramphul, Dritana Marko Serbo, Jennifer Kiger, Deborah Banerjee, Nick Bonvino, Angela Merchant, Warren Clifford, Jenny Mikhail, Hua Xu, Robert E. Murphy, Qiang Wei, Farhaan S. Vahidy, Alanna C. Morrison, Eric Boerwinkle

Understanding sociodemographic, behavioral, clinical, and laboratory risk factors in patients diagnosed with COVID-19 is critically…
Image credit
Fig 2. PCA plot of IgM and IgG pan-CoV responses. by Chaudhury et al., CC BY 4.0

PLOS ONE Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platform
June 3, 2021 Sidhartha Chaudhury, Jack Hutter, Jessica S. Bolton, Shilpa Hakre, Evelyn Mose, Amy Wooten, William O’Connell, Joseph Hudak, Shelly J. Krebs, Janice M. Darden, Jason A. Regules, Clinton K. Murray, Kayvon Modjarrad, Paul Scott, Sheila Peel, Elke S. Bergmann-Leitner

Serological assessment of SARS-CoV-2 specific responses are an essential tool for determining the prevalence of past SARS-CoV-2 infections…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, CC-0 Public Domain

PLOS ONE The benefits of coronavirus suppression: A cost-benefit analysis of the response to the first wave of COVID-19 in the United States
June 3, 2021 James Broughel, Michael Kotrous

This paper estimates the benefits and costs of state suppression policies to “bend the curve” during the initial outbreak of COVID-19 in…
Image credit
Fig 1. Flowchart of patients included in our analysis. by Sen et al., CC BY 4.0

PLOS ONE Inhaled corticosteroids do not adversely impact outcomes in COVID-19 positive patients with COPD: An analysis of Cleveland Clinic’s COVID-19 registry
June 3, 2021 Payal Sen, Uddalak Majumdar, Joe Zein, Umur Hatipoğlu, Amy H. Attaway

Inhaled Corticosteroids (ICS) are commonly prescribed to patients with severe COPD and recurrent exacerbations. It is not known what…
Image credit
Fig 2. A one-way disposable sampling valve protected participants. by Snitz et al., CC BY 4.0

PLOS ONE Proof of concept for real-time detection of SARS CoV-2 infection with an electronic nose
June 2, 2021 Kobi Snitz, Michal Andelman-Gur, Liron Pinchover, Reut Weissgross, Aharon Weissbrod, Eva Mishor, Roni Zoller, Vera Linetsky, Abebe Medhanie, Sagit Shushan, Eli Jaffe, Noam Sobel

Rapid diagnosis is key to curtailing the Covid-19 pandemic. One path to such rapid diagnosis may rely on identifying volatile organic…
Image credit
Fig 1. Timing of NPIs by country. by Banholzer et al., CC BY 4.0

PLOS ONE Estimating the effects of non-pharmaceutical interventions on the number of new infections with COVID-19 during the first epidemic wave
June 2, 2021 Nicolas Banholzer, Eva van Weenen, Adrian Lison, Alberto Cenedese, Arne Seeliger, Bernhard Kratzwald, Daniel Tschernutter, Joan Puig Salles, Pierluigi Bottrighi, Sonja Lehtinen, Stefan Feuerriegel, Werner Vach

The novel coronavirus (SARS-CoV-2) has rapidly developed into a global epidemic. To control its spread, countries have implemented…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, CC-0 Public Domain

PLOS Neglected Tropical Diseases Ivermectin as a potential treatment for COVID-19?
June 1, 2021 Olivier Chosidow, Charlotte Bernigaud, Didier Guillemot, Bruno Giraudeau, Anne Lespine, Jean-Pierre Changeux, Hervé Bourhy, Marc Lecuit, Zahir Amoura

…
Image credit
Fig 1. SDS-PAGE analysis of SARS-CoV-2 S1 spike-specific IgY carried out under reducing conditions. by Artman et al., CC BY 4.0

PLOS ONE Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replication
May 28, 2021 Chad Artman, Kyle D. Brumfield, Sahil Khanna, Julius Goepp

Background: The global pandemic of Coronavirus infectious disease 2019 (COVID-19), caused by SARS-CoV-2, has plunged the world into both…
Image credit
Fig 3. PCA plot (Day 90). by Teh et al., CC BY 4.0

PLOS ONE Multivariate visualization of the global COVID-19 pandemic: A comparison of 161 countries
May 28, 2021 Jane K. L. Teh, David A. Bradley, Jack Bee Chook, Kee Huong Lai, Woo Teck Ang, Kok Lay Teo, Suat-Cheng Peh

Background: The aim of the study was to visualize the global spread of the COVID-19 pandemic over the first 90 days, through the principal…
Image credit
Fig 2. CLIR plot by multiple conditions of 159 DBS samples with serum SARS-CoV-2 antibody results. by Turgeon et al., CC BY 4.0

PLOS ONE Validation of a multiplex flow immunoassay for detection of IgG antibodies against SARS-CoV-2 in dried blood spots
May 28, 2021 Coleman T. Turgeon, Karen A. Sanders, Piero Rinaldo, Dane Granger, Heather Hilgart, Dietrich Matern, Elitza S. Theel

Background: Dried blood spots (DBS) are an established specimen type for clinical testing given their low cost, ease of collection and…
Image credit
Fig 2. Sensitivity of PanBio Ag-RDT compared to viral load for all PCR positive cases (105 participants). by Krüger et al., CC BY 4.0

PLOS ONE The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2—Evaluation of the accuracy and ease-of-use
May 27, 2021 Lisa J. Krüger, Mary Gaeddert, Frank Tobian, Federica Lainati, Claudius Gottschalk, Julian A. F. Klein, Paul Schnitzler, Hans-Georg Kräusslich, Olga Nikolai, Andreas K. Lindner, Frank P. Mockenhaupt, Joachim Seybold, Victor M. Corman, Christian Drosten, Nira R. Pollock, Britta Knorr, Andreas Welker, Margaretha de Vos, Jilian A. Sacks, Claudia M. Denkinger, for the study team

Objectives: Diagnostics are essential for controlling the pandemic. Identifying a reliable and fast diagnostic device is needed for…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, CC-0 Public Domain

PLOS ONE Determinants of in-hospital mortality in COVID-19; a prospective cohort study from Pakistan
May 27, 2021 Samreen Sarfaraz, Quratulain Shaikh, Syed Ghazanfar Saleem, Anum Rahim, Fivzia Farooq Herekar, Samina Junejo, Aneela Hussain

A prospective cohort study was conducted at the Indus Hospital Karachi, Pakistan between March and June 2020 to estimate the in-hospital…
Image credit
Syringe and Vaccine by NIH, CC BY 2.0

PLOS ONE Willingness to participate in COVID-19 vaccine trials; a survey among a population of healthcare workers in Uganda
May 27, 2021 Jonathan Kitonsa, Onesmus Kamacooko, Ubaldo Mushabe Bahemuka, Freddie Kibengo, Ayoub Kakande, Anne Wajja, Vincent Basajja, Alfred Lumala, Edward Ssemwanga, Robert Asaba, Joseph Mugisha, Benjamin F. Pierce, Robin Shattock, Pontiano Kaleebu, Eugene Ruzagira

Background: Healthcare workers (HCWs) are at high risk of acquiring SARS-CoV-2 and COVID-19 and may therefore be a suitable population for…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, CC-0 Public Domain

PLOS ONE The systemic inflammatory response and clinicopathological characteristics in patients admitted to hospital with COVID-19 infection: Comparison of 2 consecutive cohorts
May 27, 2021 Donogh Maguire, Conor Richards, Marylynne Woods, Ross Dolan, Jesse Wilson Veitch, Wei M. J. Sim, Olivia E. H. Kemmett, David C. Milton, Sophie L. W. Randall, Ly D. Bui, Nicola Goldmann, Amy Brown, Eilidh Gillen, Allan Cameron, Barry Laird, Dinesh Talwar, Ian M. Godber, John Wadsworth, Anthony Catchpole, Alan Davidson, Donald C. McMillan

Background: In order to manage the COVID-19 systemic inflammatory response, it is important to identify clinicopathological characteristics…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, CC-0 Public Domain

PLOS ONE Seroprevalence of SARS-CoV-2 antibodies in Seattle, Washington: October 2019–April 2020
May 27, 2021 Denise J. McCulloch, Michael L. Jackson, James P. Hughes, Sandra Lester, Lisa Mills, Brandi Freeman, Mohammad Ata Ur Rasheed, Natalie J. Thornburg, Helen Y. Chu

Background: The first US case of SARS-CoV-2 infection was detected on January 20, 2020. However, some serology studies suggest SARS-CoV-2…
Image credit
Fig 2. by Dragon-Durey et al., CC BY 4.0

PLOS ONE Differential association between inflammatory cytokines and multiorgan dysfunction in COVID-19 patients with obesity
May 26, 2021 Marie-Agnès Dragon-Durey, Xiaoyi Chen, Amos Kirilovsky, Nadine Ben Hamouda, Carine El Sissy, Jules Russick, Etienne Charpentier, Yannick Binois, Florence Marliot, Maxime Meylan, Clémence Granier, Hélène Pere, Antonin Saldmann, Bastien Rance, Anne Sophie Jannot, Stéphanie Baron, Mouna Chebbi, Antoine Fayol, Nathalie Josseaume, Claire Rives-Lange, Pierre-Louis Tharaux, Bernard Cholley, Jean-Luc Diehl, Jean-Benoît Arlet, Michel Azizi, Alexandre Karras, Sébastien Czernichow, David M. Smadja, Jean-Sébastien Hulot, Isabelle Cremer, Eric Tartour, Elie Mousseaux, Franck Pagès

To investigate the mechanisms underlying the SARS-CoV-2 infection severity observed in patients with obesity, we performed a prospective…
Image credit
Fig 2. The SARS-CoV-2 outbreak in the Netherlands. by Tomokazu Konishi, CC BY 4.0

PLOS ONE SARS-CoV-2 mutations among minks show reduced lethality and infectivity to humans
May 26, 2021 Tomokazu Konishi

SARS-CoV-2 infection in minks has become a serious problem, as the virus may mutate and reinfect humans; some countries have decided to…
Image credit
Fig 3. Identiication of SARS-CoV-2 genetic clusters in different continents. by Haddad et al., CC BY 4.0

PLOS ONE SARS-CoV-2: Possible recombination and emergence of potentially more virulent strains
May 25, 2021 Dania Haddad, Sumi Elsa John, Anwar Mohammad, Maha M. Hammad, Prashantha Hebbar, Arshad Channanath, Rasheeba Nizam, Sarah Al-Qabandi, Ashraf Al Madhoun, Abdullah Alshukry, Hamad Ali, Thangavel Alphonse Thanaraj, Fahd Al-Mulla

COVID-19 is challenging healthcare preparedness, world economies, and livelihoods. The infection and death rates associated with this…
Image credit
Fig 3. by Pinzón et al., CC BY 4.0

PLOS ONE Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia
May 25, 2021 Miguel Alejandro Pinzón, Santiago Ortiz, Héctor Holguín, Juan Felipe Betancur, Doris Cardona Arango, Henry Laniado, Carolina Arias Arias, Bernardo Muñoz, Julián Quiceno, Daniel Jaramillo, Zoraida Ramirez

Background: There is no effective therapy for the severe acute respiratory syndrome by coronavirus 2 (SARS-CoV2) responsible for the…
Image credit
Fig 3. Correlation matrix among clinical variables at hospital admission and discharge. by de Almeida et al., CC BY 4.0

PLOS ONE Acute kidney injury: Incidence, risk factors, and outcomes in severe COVID-19 patients
May 25, 2021 Danilo Candido de Almeida, Maria do Carmo Pinho Franco, Davi Rettori Pardo dos Santos, Marina Colella Santos, Isabela Soucin Maltoni, Felipe Mascotte, Alexandra Aparecida de Souza, Paula Massaroni Pietrobom, Eduardo Alexandrino Medeiros, Paulo Roberto Abrão Ferreira, Flavia Ribeiro Machado, Miguel Angelo Goes

Background: COVID-19 is a multisystemic disorder that frequently causes acute kidney injury (AKI). However, the precise clinical and…
Image credit
Fig 2. Hypothetical model for thrombotic thrombocytopenia after adenoviral vector-based COVID-19 vaccines. by Goldman and Hermans, CC BY 4.0

PLOS Medicine Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity
May 24, 2021 Michel Goldman, Cédric Hermans

Michel Goldman and Cédric Hermans discuss thrombotic mechanisms in COVID-19 and rare adverse reactions to SARS-CoV-2…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, CC-0 Public Domain

PLOS Neglected Tropical Diseases COVID-19 and helminth infection: Beyond the Th1/Th2 paradigm
May 24, 2021 Alberto E. Paniz-Mondolfi, Juan David Ramírez, Lourdes A. Delgado-Noguera, Alfonso J. Rodriguez-Morales, Emilia M. Sordillo

…
Image credit
Fig 1. Forest plot of willingness to vaccinate by demographics. by Nikolovski et al., CC BY 4.0

PLOS ONE Factors indicating intention to vaccinate with a COVID-19 vaccine among older U.S. adults
May 24, 2021 Janeta Nikolovski, Martin Koldijk, Gerrit Jan Weverling, John Spertus, Mintu Turakhia, Leslie Saxon, Mike Gibson, John Whang, Troy Sarich, Robert Zambon, Nnamdi Ezeanochie, Jennifer Turgiss, Robyn Jones, Jeff Stoddard, Paul Burton, Ann Marie Navar

Background: The success of vaccination efforts to curb the COVID-19 pandemic will require broad public uptake of immunization and…
Image credit
Fig 3. Clinical SARS-CoV-2 RT-PCR sensitivity estimates in the laboratory confirmed, and in the laboratory confirmed and high suspicion group combined, presented according to delay (days) from symptom onset to sampling. by Kortela et al., CC BY 4.0

PLOS ONE Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients
May 21, 2021 Elisa Kortela, Vesa Kirjavainen, Maarit J. Ahava, Suvi T. Jokiranta, Anna But, Anna Lindahl, Anu E. Jääskeläinen, Annemarjut J. Jääskeläinen, Asko Järvinen, Pia Jokela, Hannimari Kallio-Kokko, Raisa Loginov, Laura Mannonen, Eeva Ruotsalainen, Tarja Sironen, Olli Vapalahti, Maija Lappalainen, Hanna-Riikka Kreivi, Hanna Jarva, Satu Kurkela, Eliisa Kekäläinen

Background: Understanding the false negative rates of SARS-CoV-2 RT-PCR testing is pivotal for the management of the COVID-19 pandemic and…
Image credit
Fig 1. Difference between the 2020 all-cause mortality rate and 2013–2018 historical mortality rate vs. 2020 direct COVID-19 mortality rate (n = 2,096)^a,b,c. by Stokes et al., CC BY 4.0

PLOS Medicine COVID-19 and excess mortality in the United States: A county-level analysis
May 20, 2021 Andrew C. Stokes, Dielle J. Lundberg, Irma T. Elo, Katherine Hempstead, Jacob Bor, Samuel H. Preston

Background: Coronavirus Disease 2019 (COVID-19) excess deaths refer to increases in mortality over what would normally have been expected…
Image credit
Fig 3. Geographical distribution of pregnant women with COVID-19, and medical facilities where community-acquired infection of COVID-19 occurred in Japan (-2020 June). by Hasegawa et al., CC BY 4.0

PLOS ONE Current status of community-acquired infection of COVID-19 in delivery facilities in Japan
May 20, 2021 Junichi Hasegawa, Tatsuya Arakaki, Akihiko Sekizawa, Tomoaki Ikeda, Isamu Ishiwata, Katsuyuki Kinoshita, on behalf of department of medical safety, the Japan Association of Obstetricians and Gynecologists (JAOG)

A nationwide questionnaire survey about community-acquired infection of coronavirus disease 2019 (COVID-19) was conducted in July 2020 to…
Image credit
Fig 3. Funnel plot of the association between the DPP-4i use and the mortality of COVID-19. by Yang et al., CC BY 4.0

PLOS ONE DPP-4 inhibitors may improve the mortality of coronavirus disease 2019: A meta-analysis
May 20, 2021 Yan Yang, Zixin Cai, Jingjing Zhang

Aims: DPP-4 inhibitors are predicted to exert a protective effect on the progression of coronavirus disease 2019 (COVID-19). We conducted…
Image credit
Fig 7. Receiver operating characteristic (ROC) curves analysis of total score for assessing the risk of respiratory support in COVID-19. by Rorat et al., CC BY 4.0

PLOS ONE Value of quantitative analysis in lung computed tomography in patients severely ill with COVID-19
May 20, 2021 Marta Rorat, Tomasz Jurek, Krzysztof Simon, Maciej Guziński

Introduction: Quantitative computed tomography (QCT) is used to objectively assess the degree of parenchymal impairment in COVID-19…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, CC-0 Public Domain

PLOS ONE Incidence of deep vein thrombosis through an ultrasound surveillance protocol in patients with COVID-19 pneumonia in non-ICU setting: A multicenter prospective study
May 20, 2021 Filippo Pieralli, Fulvio Pomero, Margherita Giampieri, Rossella Marcucci, Domenico Prisco, Fabio Luise, Antonio Mancini, Alessandro Milia, Lucia Sammicheli, Irene Tassinari, Francesca Caldi, Francesca Innocenti, Antonio Faraone, Chiara Beltrame, Riccardo Pini, Andrea Ungar, Alberto Fortini

Objective: The aim of this study was to assess the incidence of deep vein thrombosis (DVT) of the lower limbs, using serial compression…
Image credit
Fig 2. OneR model diagnostic plot. by Herzog et al., CC BY 4.0

PLOS ONE COVID-19 and the kidney: A retrospective analysis of 37 critically ill patients using machine learning
May 20, 2021 Anna Laura Herzog, Holger K. von Jouanne-Diedrich, Christoph Wanner, Dirk Weismann, Tobias Schlesinger, Patrick Meybohm, Jan Stumpner

Introduction: There is evidence that SARS-CoV2 has a particular affinity for kidney tissue and is often associated with kidney failure.…
Image credit
Untitled by Dellicour et al., CC BY 4.0

PLOS Pathogens Dispersal dynamics of SARS-CoV-2 lineages during the first epidemic wave in New York City
May 20, 2021 Simon Dellicour, Samuel L. Hong, Bram Vrancken, Antoine Chaillon, Mandev S. Gill, Matthew T. Maurano, Sitharam Ramaswami, Paul Zappile, Christian Marier, Gordon W. Harkins, Guy Baele, Ralf Duerr, Adriana Heguy

During the first phase of the COVID-19 epidemic, New York City rapidly became the epicenter of the pandemic in the United States. While…
Image credit
Fig 2. Neuron-Specific Enolase (NSE) serum levels. by Cione et al., CC BY 4.0

PLOS ONE Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury
May 19, 2021 Erika Cione, Antonio Siniscalchi, Pietro Gangemi, Lucio Cosco, Manuela Colosimo, Federico Longhini, Filippo Luciani, Giovambattista De Sarro, G&SP Working Group , Liberato Berrino, Bruno D’Agostino, Luca Gallelli

The multifunctional role of neuron-specific enolase (NSE) in lung diseases is well established. As the lungs are greatly affected in…
Image credit
Pregnant woman by sergio santos, CC BY 2.0

PLOS ONE Available medications used as potential therapeutics for COVID-19: What are the known safety profiles in pregnancy
May 19, 2021 Anick Bérard, Odile Sheehy, Jin-Ping Zhao, Evelyne Vinet, Caroline Quach, Behrouz Kassai, Sasha Bernatsky

Background: Medications already available to treat other conditions are presently being studied in clinical trials as potential treatments…
Image credit
Untitled by Garzon-Chavez et al., CC BY 4.0

PLOS ONE Adapting for the COVID-19 pandemic in Ecuador, a characterization of hospital strategies and patients
May 17, 2021 Daniel Garzon-Chavez, Daniel Romero-Alvarez, Marco Bonifaz, Juan Gaviria, Daniel Mero, Narcisa Gunsha, Asiris Perez, María Garcia, Hugo Espejo, Franklin Espinosa, Edison Ligña, Mauricio Espinel, Emmanuelle Quentin, Enrique Teran, Francisco Mora, Jorge Reyes

The World Health Organization (WHO) declared coronavirus disease-2019 (COVID-19) a global pandemic on 11 March 2020. In Ecuador, the first…
Image credit
Fig 2. Resonant frequencies f (in GHz) corresponding to respective V_L (in m/s) for different diameters D (in nm) of EV71 virus. by Barbora and Minnes, CC BY 4.0

PLOS ONE Targeted antiviral treatment using non-ionizing radiation therapy for SARS-CoV-2 and viral pandemics preparedness: Technique, methods and practical notes for clinical application
May 14, 2021 Ayan Barbora, Refael Minnes

Objective: Pandemic outbreaks necessitate effective responses to rapidly mitigate and control the spread of disease and eliminate the…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, CC-0 Public Domain

PLOS ONE The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients
May 14, 2021 Giulia Besutti, Massimo Pellegrini, Marta Ottone, Michele Cantini, Jovana Milic, Efrem Bonelli, Giovanni Dolci, Giulia Cassone, Guido Ligabue, Lucia Spaggiari, Pierpaolo Pattacini, Tommaso Fasano, Simone Canovi, Marco Massari, Carlo Salvarani, Giovanni Guaraldi, Paolo Giorgi Rossi, on behalf of the Reggio Emilia COVID-19 Working Group

We assessed the impact of chest CT body composition parameters on outcomes and disease severity at hospital presentation of COVID-19…
Image credit
Fig 1. Temporal distribution of COVID-19 cases and their deaths in the capitals of the Northeast of Brazil. by Costa de Assis et al., CC BY 4.0

PLOS ONE Primary health care and social isolation against COVID-19 in Northeastern Brazil: Ecological time-series study
May 13, 2021 Sanderson José Costa de Assis, Johnnatas Mikael Lopes, Marcello Barbosa Otoni Gonçalves Guedes, Geronimo José Bouzas Sanchis, Diego Neves Araujo, Angelo Giuseppe Roncalli

Background: Brazil is witnessing a massive increase of corona virus disease (COVID-19). Its peculiar primary health care (PHC) system faces…
Image credit
Fig 4. Lockdown and travel restriction policy intensity from government and agent over time. by Kwak et al., CC BY 4.0

PLOS ONE Deep reinforcement learning approaches for global public health strategies for COVID-19 pandemic
May 13, 2021 Gloria Hyunjung Kwak, Lowell Ling, Pan Hui

Background: Unprecedented public health measures have been used during this coronavirus 2019 (COVID-19) pandemic to control the spread of…
Image credit
Fig 3. p-values of the differences between non-ARDS patients and ARDS patients for the four immunoassays at different time points. by Buchholtz et al., CC BY 4.0

PLOS ONE SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS
May 13, 2021 Marie-Luise Buchholtz, Florian M. Arend, Peter Eichhorn, Michael Weigand, Alisa Kleinhempel, Kurt Häusler, Mathias Bruegel, Lesca M. Holdt, Daniel Teupser

Objectives: During the COVID-19 pandemic, SARS-CoV-2 antibody testing has been suggested for (1) screening populations for disease…
Image credit
Fig 2. by Peng et al., CC BY 4.0

PLOS ONE Clinical course and management of 73 hospitalized moderate patients with COVID-19 outside Wuhan
May 13, 2021 Xiaojuan Peng, Qi Liu, Zhaolin Chen, Guiyan Wen, Qing Li, Yanfang Chen, Jie Xiong, Xinzhou Meng, Yuanjin Ding, Ying Shi, Shaohui Tang

Moderate cases account for the majority in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…
Image credit
Fig 1. Scheme of the possible infection rules according to RhD blood types and ABO ones. by Miotto et al., CC BY 4.0

PLOS ONE Does blood type affect the COVID-19 infection pattern?
May 13, 2021 Mattia Miotto, Lorenzo Di Rienzo, Giorgio Gosti, Edoardo Milanetti, Giancarlo Ruocco

Among the many aspects that characterize the COVID-19 pandemic, two seem particularly challenging to understand: i) the great geographical…
Image credit
Fig 2. Diagram for the flow of participants for part 2 of the study (qRT-PCR positive participants only). by Van der Moeren et al., CC BY 4.0

PLOS ONE Evaluation of the test accuracy of a SARS-CoV-2 rapid antigen test in symptomatic community dwelling individuals in the Netherlands
May 13, 2021 Nathalie Van der Moeren, Vivian F. Zwart, Esther B. Lodder, Wouter Van den Bijllaardt, Harald R. J. M. Van Esch, Joep J. J. M. Stohr, Joost Pot, Ineke Welschen, Petra M. F. Van Mechelen, Suzan D. Pas, Jan A. J. W. Kluytmans

Background: SARS-CoV-2 real-time reverse transcriptase polymerase chain reaction (qRT-PCR) is well suited for the diagnosis of clinically…
Image credit
Fig 1. Location of Mutukula border entry point into Uganda. by Nsawotebba et al., CC BY 4.0

PLOS ONE Effectiveness of thermal screening in detection of COVID-19 among truck drivers at Mutukula Land Point of Entry, Uganda
May 13, 2021 Andrew Nsawotebba, Ivan Ibanda, Isaac Ssewanyana, Patrick Ogwok, Francis Ocen, Christopher Okiira, Atek Kagirita, Dennis Mujuni, Didas Tugumisirize, Joel Kabugo, Abdunoor Nyombi, Robert Kaos Majwala, Bernard Ssentalo Bagaya, Simeon Kalyesubula-Kibuuka, Willy Ssengooba, Susan Nabadda

Introduction: Despite the limited evidence for its effectiveness, thermal screening at points of entry has increasingly become a standard…
Image credit
Fig 1. COVID-19 postmortem donor eye. by Bayyoud et al., CC BY 4.0

PLOS ONE Severe acute respiratory Syndrome-Coronavirus-2: Can it be detected in the retina?
May 13, 2021 Tarek Bayyoud, Angelika Iftner, Thomas Iftner, Karl Ulrich Bartz-Schmidt, Focke Ziemssen, Hans Bösmüller, Falko Fend, Jens Martin Rohrbach, Marius Ueffing, Michael Schindler, Sebastian Thaler

Background/Objectives: The systemic organ involvement of SARS-CoV-2 needs to be thoroughly investigated including the possibility of an…
Image credit
Fig 1. Changes in FEV₁ (% of predicted) among patients who tested positive for SARS-CoV-2 (cases) by PCR analysis and those who tested negative (controls)^a. by Colombo et al., CC BY 4.0

PLOS ONE SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020
May 13, 2021 Carla Colombo, Gianfranco Alicandro, Valeria Daccó, Vanessa Gagliano, Letizia Corinna Morlacchi, Rosaria Casciaro, Giovanna Pisi, Michela Francalanci, Raffaele Badolato, Elisabetta Bignamini, Barbara Messore, Maria Cristina Lucanto, Giuseppina Leonetti, Massimo Maschio, Marco Cipolli, on behalf of the Italian Cystic Fibrosis Society (SIFC) Study Group for COVID-19

Objective: To describe the symptoms and clinical course of SARS-CoV-2 infection in patients with cystic fibrosis (CF). Methods: We carried…
Image credit
Fig 3. Heat map of phenotypes associated with COVID-19 outcomes. by Song et al., CC BY 4.0

PLOS ONE Phenome-wide association of 1809 phenotypes and COVID-19 disease progression in the Veterans Health Administration Million Veteran Program
May 13, 2021 Rebecca J. Song, Yuk-Lam Ho, Petra Schubert, Yojin Park, Daniel Posner, Emily M. Lord, Lauren Costa, Hanna Gerlovin, Katherine E. Kurgansky, Tori Anglin-Foote, Scott DuVall, Jennifer E. Huffman, Saiju Pyarajan, Jean C. Beckham, Kyong-Mi Chang, Katherine P. Liao, Luc Djousse, David R. Gagnon, Stacey B. Whitbourne, Rachel Ramoni, Sumitra Muralidhar, Philip S. Tsao, Christopher J. O’Donnell, John Michael Gaziano, Juan P. Casas, Kelly Cho, on behalf of the VA Million Veteran Program COVID-19 Science Initiative

Background: The risk factors associated with the stages of Coronavirus Disease-2019 (COVID-19) disease progression are not well known. We…
Image credit
Fig 1. Projections of daily PEH isolation bed demand with 95% prediction intervals under seven intervention scenarios. by Ingle et al., CC BY 4.0

PLOS ONE Projecting COVID-19 isolation bed requirements for people experiencing homelessness
May 12, 2021 Tanvi A. Ingle, Maike Morrison, Xutong Wang, Timothy Mercer, Vella Karman, Spencer Fox, Lauren Ancel Meyers

As COVID-19 spreads across the United States, people experiencing homelessness (PEH) are among the most vulnerable to the virus. To…
Image credit
Fig 1. Epidemic curve of COVID-19 cases at the Djoungolo Hospital. by Fouda Mbarga et al., CC BY 4.0

PLOS ONE Clinical profile and factors associated with COVID-19 in Yaounde, Cameroon: A prospective cohort study
May 12, 2021 Nicole Fouda Mbarga, Emilienne Epee, Marcel Mbarga, Patrick Ouamba, Herwin Nanda, Aristide Nkengni, Joseph Guekeme, Justin Eyong, Sylvie Tossoukpe, Sauvia Noumedem Sosso, Engelbert Ngono Ngono, Lazare Mbala Ntsama, Landry Bonyomo, Patrick Tchatchoua, Noel Vogue, Steve Metomb, Franck Ale, Moussa Ousman, Dorian Job, Charlotte Moussi, Modeste Tamakloe, Jessica E. Haberer, Sylvester Ndeso Atanga, Gregory Halle-Ekane, Yap Boum II

Background: A year after the COVID-19 pandemic started, there are still few scientific reports on COVID-19 in Africa. This study explores…
Image credit
Fig 2. Lopinavir/ritonavir and hydroxychloroquine (triple therapy) are associated with an increase in the incidence of Acute Kidney Injury (AKI). by Schneider et al., CC BY 4.0

PLOS ONE Therapy with lopinavir/ritonavir and hydroxychloroquine is associated with acute kidney injury in COVID-19 patients
May 11, 2021 Johanna Schneider, Bernd Jaenigen, Dirk Wagner, Siegbert Rieg, Daniel Hornuss, Paul M. Biever, Winfried V. Kern, Gerd Walz

Background: Acute kidney injury (AKI) is an independent risk factor for mortality, which affects about 5% of hospitalized coronavirus…
Image credit
Fig 2. Raspberry Pi 4 model B hardware design. by Hosny et al., CC BY 4.0

PLOS ONE COVID-19 diagnosis from CT scans and chest X-ray images using low-cost Raspberry Pi
May 11, 2021 Khalid M. Hosny, Mohamed M. Darwish, Kenli Li, Ahmad Salah

The diagnosis of COVID-19 is of vital demand. Several studies have been conducted to decide whether the chest X-ray and computed…
Image credit
Fig 2. Antibiotic prescription variation over time. by Calderón-Parra et al., CC BY 4.0

PLOS ONE Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID
May 11, 2021 Jorge Calderón-Parra, Antonio Muiño-Miguez, Alejandro D. Bendala-Estrada, Antonio Ramos-Martínez, Elena Muñez-Rubio, Eduardo Fernández Carracedo, Javier Tejada Montes, Manuel Rubio-Rivas, Francisco Arnalich-Fernandez, Jose Luis Beato Pérez, Jose Miguel García Bruñén, Esther del Corral Beamonte, Paula Maria Pesqueira Fontan, Maria del Mar Carmona, Rosa Fernández-Madera Martínez, Andrés González García, Cristina Salazar Mosteiro, Carlota Tuñón de Almeida, Julio González Moraleja, Francesco Deodati, María Dolores Martín Escalante, María Luisa Asensio Tomás, Ricardo Gómez Huelgas, José Manuel Casas Rojo, Jesús Millán Núñez-Cortés, for the SEMI-COVID-19 Network

Background: Most patients with COVID-19 receive antibiotics despite the fact that bacterial co-infections are rare. This can lead to…
Image credit
Fig 2. Locations of ICU responders. by Brewster et al., CC BY 4.0

PLOS ONE Preparation for airway management in Australia and New Zealand ICUs during the COVID -19 pandemic
May 7, 2021 David J. Brewster, Christopher P. Nickson, Steve McGloughlin, David Pilcher, Vineet V. Sarode, Jonathan J. Gatward

Background: This paper aimed to describe the airway practices of intensive care units (ICUs) in Australia and New Zealand specific to…
Image credit
Fig 3. Top row left-to-right: Confusion matrices for ai-corona, the model proposed by Zhang et al. [29], and the model proposed by Jin et al. [30] for the CC-CCI test set, respectively. by Yousefzadeh et al., CC BY 4.0

PLOS ONE ai-corona: Radiologist-assistant deep learning framework for COVID-19 diagnosis in chest CT scans
May 7, 2021 Mehdi Yousefzadeh, Parsa Esfahanian, Seyed Mohammad Sadegh Movahed, Saeid Gorgin, Dara Rahmati, Atefeh Abedini, Seyed Alireza Nadji, Sara Haseli, Mehrdad Bakhshayesh Karam, Arda Kiani, Meisam Hoseinyazdi, Jafar Roshandel, Reza Lashgari

The development of medical assisting tools based on artificial intelligence advances is essential in the global fight against COVID-19…
Image credit
Fig 1. Evolution of cumulative cases, deaths, and policy milestones in Chile and the Metropolitan Region (March-July, 2020). by Villalobos Dintrans et al., CC BY 4.0

PLOS ONE COVID-19 incidence and mortality in the Metropolitan Region, Chile: Time, space, and structural factors
May 6, 2021 Pablo Villalobos Dintrans, Claudio Castillo, Felipe de la Fuente, Matilde Maddaleno

Demographic, health, and socioeconomic factors significantly inform COVID-19 outcomes. This article analyzes the association of these…
Image credit
Fig 3. Forest plot of pooled prevalence of superinfection in patients infected with SARS-CoV-2. by Musuuza et al., CC BY 4.0

PLOS ONE Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis
May 6, 2021 Jackson S. Musuuza, Lauren Watson, Vishala Parmasad, Nathan Putman-Buehler, Leslie Christensen, Nasia Safdar

Introduction: The recovery of other pathogens in patients with SARS-CoV-2 infection has been reported, either at the time of a SARS-CoV-2…
Image credit
Fig 1. Sense of preparedness to serve in COVID-19 pandemic. by Barqawi et al., CC BY 4.0

PLOS ONE Readiness of physicians and medical students to cope with the COVID-19 pandemic in the UAE
May 6, 2021 Hiba J. Barqawi, Drishti D. Kampani, Enad S. Haddad, Nora M. Al-Roub, Eman Abu-Gharbieh

Background: Coronavirus disease (COVID-19), caused by Severe Acute Respiratory Syndrome–Coronavirus 2 (SARS-CoV2), is the defining global…
Image credit
Fig 1. Correlogram figuring out the relationship between each pair of clinical or biological variables in COVID-19 patients. by Bats et al., CC BY 4.0

PLOS ONE Covichem: A biochemical severity risk score of COVID-19 upon hospital admission
May 6, 2021 Marie-Lise Bats, Benoit Rucheton, Tara Fleur, Arthur Orieux, Clément Chemin, Sébastien Rubin, Brigitte Colombies, Arnaud Desclaux, Claire Rivoisy, Etienne Mériglier, Etienne Rivière, Alexandre Boyer, Didier Gruson, Isabelle Pellegrin, Pascale Trimoulet, Isabelle Garrigue, Rana Alkouri, Charles Dupin, François Moreau-Gaudry, Aurélie Bedel, Sandrine Dabernat

Clinical and laboratory predictors of COVID-19 severity are now well described and combined to propose mortality or severity scores.…
Image credit
Fig 1. Geographic location of sample collection sites in this study. by Megasari et al., CC BY 4.0

PLOS ONE Seroepidemiological study of SARS-CoV-2 infection in East Java, Indonesia
May 6, 2021 Ni Luh Ayu Megasari, Takako Utsumi, Laura Navika Yamani, Juniastuti, Emily Gunawan, Koichi Furukawa, Mitsuhiro Nishimura, Maria Inge Lusida, Yasuko Mori

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a global pandemic,…
Image credit
run by brett lohmeyer, CC BY 2.0

PLOS ONE The association of estimated cardiorespiratory fitness with COVID-19 incidence and mortality: A cohort study
May 5, 2021 Rebecca A. G. Christensen, Jasleen Arneja, Kate St. Cyr, Shelby L. Sturrock, Jennifer D. Brooks

Background: It has been suggested that cardiorespiratory fitness (CRF) may be used to identify those at greatest risk for severe COVID-19…
Image credit
Fig 2. RT-LAMP assay limit of detection. by Uribe-Alvarez et al., CC BY 4.0

PLOS ONE Low saliva pH can yield false positives results in simple RT-LAMP-based SARS-CoV-2 diagnostic tests
May 5, 2021 Cristina Uribe-Alvarez, Quynh Lam, Don A. Baldwin, Jonathan Chernoff

Diagnosis of any infectious disease is vital for opportune treatment and to prevent dissemination. RT-qPCR tests for detection of…
Image credit
Fig 1. Number of pregnant women admitted to hospital with symptomatic and asymptomatic confirmed SARS-CoV-2 infection in the UK between 1^st March and 31^{st by Vousden et al.,}CC BY 4.0

PLOS ONE The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: A national cohort study using the UK Obstetric Surveillance System (UKOSS)
May 5, 2021 Nicola Vousden, Kathryn Bunch, Edward Morris, Nigel Simpson, Christopher Gale, Patrick O’Brien, Maria Quigley, Peter Brocklehurst, Jennifer J. Kurinczuk, Marian Knight

Background: There is a lack of population level data on risk factors, incidence and impact of SARS-CoV-2 infection in pregnant women and…
Image credit
Fig 1. Schematic diagram of the seven steps of the methodological framework according to PRISMA. by Dzinamarira et al., CC BY 4.0

PLOS ONE Risk factors for COVID-19 among healthcare workers. A protocol for a systematic review and meta-analysis
May 4, 2021 Tafadzwa Dzinamarira, Malizgani Mhango, Mathias Dzobo, Bernard Ngara, Itai Chitungo, Pelagia Makanda, James Atwine, Sphamandla Josias Nkambule, Godfrey Musuka

Background: Evidence on the spectrum of risk factors for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among…
Image credit
Fig 3. Interval from initial to recurrent positive SARS-CoV-2 RT-PCR. by Peltan et al., CC BY 4.0

PLOS ONE Evaluation of potential COVID-19 recurrence in patients with late repeat positive SARS-CoV-2 testing
May 4, 2021 Ithan D. Peltan, Sarah J. Beesley, Brandon J. Webb, Bert K. Lopansri, Will Sinclair, Jason R. Jacobs, Samuel M. Brown

Background: SARS-CoV-2 reinfection and reactivation has mostly been described in case reports. We therefore investigated the epidemiology…
Image credit
Fig 5. Meta-regression by median age of patients. by Li et al., CC BY 4.0

PLOS ONE Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis
May 3, 2021 Xinyang Li, Xianrui Zhong, Yongbo Wang, Xiantao Zeng, Ting Luo, Qing Liu

Objective: We aimed to systematically identify the possible risk factors responsible for severe cases. Methods: We searched PubMed, Embase,…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, CC-0 Public Domain

PLOS ONE Low serum albumin and the risk of hospitalization in COVID-19 infection: A retrospective case-control study
April 30, 2021 Roshan Acharya, Dilli Poudel, Aakash Patel, Evan Schultz, Michael Bourgeois, Rishi Paswan, Scott Stockholm, Macylen Batten, Smita Kafle, Amanda Atkinson, Hafiz Sarwar

Background: The data on the COVID-19 patients who were discharged to self-quarantine is lacking. Aim: The aim of the study was to…
Image credit
Fig 2. by Elhadi et al., CC BY 4.0

PLOS ONE Epidemiology, outcomes, and utilization of intensive care unit resources for critically ill COVID-19 patients in Libya: A prospective multi-center cohort study
April 30, 2021 Muhammed Elhadi, Ahmed Alsoufi, Abdurraouf Abusalama, Akram Alkaseek, Saedah Abdeewi, Mohammed Yahya, Alsnosy Mohammed, Mohammed Abdelkabir, Mohammed Huwaysh, Emad Amkhatirah, Kamel Alshorbaji, Samer Khel, Marwa Gamra, Abdulmueti Alhadi, Taha Abubaker, Mohamed Anaiba, Mohammed Elmugassabi, Muhannud Binnawara, Ala Khaled, Ahmed Zaid, Ahmed Msherghi

Background: The coronavirus disease (COVID-19) pandemic has severely affected African countries, specifically the countries, such as Libya,…
Image credit
Fig 2. Graph plotting raw Ct values (y-axis) for all 641 positive samples in the Birmingham Turnkey lab (y-axis). by Ferguson et al., CC BY 4.0

PLOS Biology Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: Testing frequency and public health messaging is key
April 29, 2021 Jack Ferguson, Steven Dunn, Angus Best, Jeremy Mirza, Benita Percival, Megan Mayhew, Oliver Megram, Fiona Ashford, Thomas White, Emma Moles-Garcia, Liam Crawford, Tim Plant, Andrew Bosworth, Michael Kidd, Alex Richter, Jonathan Deeks, Alan McNally

Lateral flow devices (LFDs) are quickly being implemented for use in large-scale population surveillance programs for SARS-CoV-2 infection…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, CC-0 Public Domain

PLOS ONE Risk factors for COVID-19 mortality: The effect of convalescent plasma administration
April 29, 2021 Martín R. Salazar, Soledad E. González, Lorena Regairaz, Noelia S. Ferrando, Verónica V. González Martínez, Patricia M. Carrera Ramos, Laura Muñoz, Santiago A. Pesci, Juan M. Vidal, Nicolás Kreplak, Elisa Estenssoro

Background: Convalescent plasma, widely utilized in viral infections that induce neutralizing antibodies, has been proposed for COVID-19,…
Image credit
Novel Coronavirus SARS-CoV-2 Spike Protein by NIH, CC-0 Public Domain

PLOS ONE Epidemiological, clinical, and laboratory findings for patients of different age groups with confirmed coronavirus disease 2019 (COVID-19) in a hospital in Saudi Arabia
April 29, 2021 Mutasim E. Ibrahim, Obaid S. AL-Aklobi, Mosleh M. Abomughaid, Mushabab A. Al-Ghamdi

Background: Although the coronavirus disease 2019 (COVID-19) pandemic continues to rage worldwide, clinical and laboratory studies of this…
Image credit
Novel Coronavirus SARS-CoV-2 by NIH, CC-0 Public Domain

PLOS ONE Assessment of exposure risks to COVID-19 among frontline health care workers in Amhara Region, Ethiopia: A cross-sectional survey
April 29, 2021 Seyfe Asrade Atnafie, Demssie Ayalew Anteneh, Dawit Kumilachew Yimenu, Zemene Demelash Kifle

Background: The burden to fight with Corona Virus Disease-19 (COVID-19) pandemic has lied to frontline health care workers that are putting…
Image credit
Fig 3. The pooled male to female CFRR (for seven countries) by age group together with the 95% CI lower and upper limits, derived from the meta-analysis. by Green et al., CC BY 4.0

PLOS ONE Sex differences in the case-fatality rates for COVID-19—A comparison of the age-related differences and consistency over seven countries
April 29, 2021 Manfred S. Green, Dorit Nitzan, Naama Schwartz, Yaron Niv, Victoria Peer

Background: Early in the COVID-19 pandemic, it was noted that males seemed to have higher case-fatality rates than females. We examined the…
Image credit
Fig 3. Serum Krebs von den lungen (KL-6) levels in patients with abnormal CT scans at 12 weeks. by Arnold et al., CC BY 4.0

PLOS ONE Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks
April 29, 2021 David T. Arnold, Charmaine Donald, Max Lyon, Fergus W. Hamilton, Anna J. Morley, Marie Attwood, Alexandra Dipper, Shaney L. Barratt

Introduction: Acute presentations of COVID-19 infection vary, ranging from asymptomatic carriage through to severe clinical manifestations…
Image credit
Fig 1. Age distribution of patients stratified by clinical outcome. by Salto-Alejandre et al., CC BY 4.0

PLOS ONE Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study
April 29, 2021 Sonsoles Salto-Alejandre, Silvia Jiménez-Jorge, Nuria Sabé, Antonio Ramos-Martínez, Laura Linares, Maricela Valerio, Pilar Martín-Dávila, Mario Fernández-Ruiz, María Carmen Fariñas, Marino Blanes-Juliá, Elisa Vidal, Zaira R. Palacios-Baena, Román Hernández-Gallego, Jordi Carratalá, Jorge Calderón-Parra, María Ángeles Marcos, Patricia Muñoz, Jesús Fortún-Abete, José María Aguado, Francisco Arnaiz-Revillas, Rosa Blanes-Hernández, Julián de la Torre-Cisneros, Luis E. López-Cortés, Elena García de Vinuesa-Calvo, Clara M. Rosso, Jerónimo Pachón, Javier Sánchez-Céspedes, Elisa Cordero, on behalf of The COVIDSOT Working Team

The aim was to analyze the characteristics and predictors of unfavorable outcomes in solid organ transplant recipients (SOTRs) with…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID-RML, CC-0 Public Domain

PLOS ONE Two original observations concerning bacterial infections in COVID-19 patients hospitalized in intensive care units during the first wave of the epidemic in France
April 29, 2021 Camille d’Humières, Juliette Patrier, Brice Lortat-Jacob, Alexy Tran-dinh, Lotfi Chemali, Naouale Maataoui, Emilie Rondinaud, Etienne Ruppé, Charles Burdet, Stéphane Ruckly, Philippe Montravers, Jean-François Timsit, Laurence Armand-Lefevre

Among 197 COVID-19 patients hospitalized in ICU, 88 (44.7%) experienced at least one bacterial infection, with pneumonia (39.1%) and…
Image credit
Fig 2. Patients working in a vital profession (A) and in the medical sector (B) in the SARS-Cov-2 positive-tested, negative-tested, and control groups. by van der Valk et al., CC BY 4.0

PLOS ONE Case-control study of patient characteristics, knowledge of the COVID-19 disease, risk behaviour and mental state in patients visiting an emergency room with COVID-19 symptoms in the Netherlands
April 28, 2021 J. P. M. van der Valk, F. W. J. Heijboer, H. van Middendorp, A. W. M. Evers, J. C. C. M. in ‘t Veen

Background: Coronavirus disease 2019 is a serious respiratory virus pandemic. Patient characteristics, knowledge of the COVID-19 disease,…
Image credit
Fig 1. Comparison of Genalyte target-specific results with Beckman and DiaSorin results. by Ikegami et al., CC BY 4.0

PLOS ONE Target specific serologic analysis of COVID-19 convalescent plasma
April 28, 2021 Sachie Ikegami, Robert C. Benirschke, Hossein Fakhrai-Rad, Mohammad H. Motamedi, Rick Hockett, Sean David, Hong Kee Lee, Jason Kang, Thomas J. Gniadek

This study compared the performance of four serology assays for Coronavirus Disease 2019 (COVID-19) and investigated whether COVID-19…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID-RML, CC-0 Public Domain

PLOS ONE Pathological findings in organs and tissues of patients with COVID-19: A systematic review
April 28, 2021 Sasha Peiris, Hector Mesa, Agnes Aysola, Juan Manivel, Joao Toledo, Marcio Borges-Sa, Sylvain Aldighieri, Ludovic Reveiz

Background: Coronavirus disease (COVID-19) is the pandemic caused by SARS-CoV-2 that has caused more than 2.2 million deaths worldwide. We…
Image credit
Fig 1. Daily hospitalization incidence (rate per million population per day) in the absence of vaccination for varying level of public policy response, 2020–2022. by Coudeville et al., CC BY 4.0

PLOS ONE Potential impact of introducing vaccines against COVID-19 under supply and uptake constraints in France: A modelling study
April 28, 2021 Laurent Coudeville, Ombeline Jollivet, Cedric Mahé, Sandra Chaves, Gabriela B. Gomez

Background: The accelerated vaccine development in response to the COVID-19 pandemic should lead to a vaccine being available early 2021,…
Image credit
Fig 1. Blood donor demographics of NYC metro area. by Jin et al., CC BY 4.0

PLOS ONE Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and “Reopening”
April 28, 2021 Daniel K. Jin, Daniel J. Nesbitt, Jenny Yang, Haidee Chen, Julie Horowitz, Marcus Jones, Rianna Vandergaast, Timothy Carey, Samantha Reiter, Stephen J. Russell, Christos Kyratsous, Andrea Hooper, Jennifer Hamilton, Manuel Ferreira, Sarah Deng, Donna Straus, Aris Baras, Christopher D. Hillyer, Larry L. Luchsinger

Projections of the stage of the Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) pandemic and local, regional and national…
Image credit
thanksgiving dinner-45.jpg by barbbarbbarb, CC BY 2.0

PLOS ONE Investigation of SARS-CoV-2 infection in dogs and cats of humans diagnosed with COVID-19 in Rio de Janeiro, Brazil
April 28, 2021 Guilherme Amaral Calvet, Sandro Antonio Pereira, Maria Ogrzewalska, Alex Pauvolid-Corrêa, Paola Cristina Resende, Wagner de Souza Tassinari, Anielle de Pina Costa, Lucas Oliveira Keidel, Alice Sampaio Barreto da Rocha, Michele Fernanda Borges da Silva, Shanna Araujo dos Santos, Ana Beatriz Machado Lima, Isabella Campos Vargas de Moraes, Artur Augusto Velho Mendes Junior, Thiago das Chagas Souza, Ezequias Batista Martins, Renato Orsini Ornellas, Maria Lopes Corrêa, Isabela Maria da Silva Antonio, Lusiele Guaraldo, Fernando do Couto Motta, Patrícia Brasil, Marilda Mendonça Siqueira, Isabella Dib Ferreira Gremião, Rodrigo Caldas Menezes

Background: Infection by SARS-CoV-2 in domestic animals has been related to close contact with humans diagnosed with COVID-19. Objectives:…
Image credit
Fig 2. by Chen et al., CC BY 4.0

PLOS ONE Hypertension as a sequela in patients of SARS-CoV-2 infection
April 28, 2021 Ganxiao Chen, Xun Li, Zuojiong Gong, Hao Xia, Yao Wang, Xuefen Wang, Yan Huang, Hector Barajas-Martinez, Dan Hu

Background: COVID-19 is a respiratory infectious disease caused by SARS-CoV-2, and cardiovascular damage is commonly observed in affected…
Image credit
Fig 3. SARS-CoV-2 mutants with one or two mildly deleterious mutations are expected to exist at high numbers. by Van Egeren et al., CC BY 4.0

PLOS ONE Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein
April 28, 2021 Debra Van Egeren, Alexander Novokhodko, Madison Stoddard, Uyen Tran, Bruce Zetter, Michael Rogers, Bradley L. Pentelute, Jonathan M. Carlson, Mark Hixon, Diane Joseph-McCarthy, Arijit Chakravarty

The spike protein receptor-binding domain (RBD) of SARS-CoV-2 is the molecular target for many vaccines and antibody-based prophylactics…
Image credit
Fig 1. The association of inflammatory markers with death and ICU admission in men and women with COVID-19 infection. by Lau et al., CC BY 4.0

PLOS ONE Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: Insights from the MGH COVID-19 patient registry
April 28, 2021 Emily S. Lau, Jenna N. McNeill, Samantha M. Paniagua, Elizabeth E. Liu, Jessica K. Wang, Ingrid V. Bassett, Caitlin A. Selvaggi, Steven A. Lubitz, Andrea S. Foulkes, Jennifer E. Ho

Background: Men are at higher risk for serious complications related to COVID-19 infection than women. More robust immune activation in…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID-RML, CC-0 Public Domain

PLOS ONE Willingness to vaccinate against COVID-19 among Bangladeshi adults: Understanding the strategies to optimize vaccination coverage
April 27, 2021 Minhazul Abedin, Mohammad Aminul Islam, Farah Naz Rahman, Hasan Mahmud Reza, Mohammad Zakir Hossain, Mohammad Anwar Hossain, Adittya Arefin, Ahmed Hossain

Background: Although the approved COVID-19 vaccine has been shown to be safe and effective, mass vaccination in Bangladeshi people remains…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID-RML, CC-0 Public Domain

PLOS Pathogens Individuals cannot rely on COVID-19 herd immunity: Durable immunity to viral disease is limited to viruses with obligate viremic spread
April 26, 2021 Jonathan W. Yewdell

…
Image credit
Fig 1. Epidemiological characteristics of COVID-19 in Africa. by Lamptey et al., CC BY 4.0

PLOS Neglected Tropical Diseases Genomic and epidemiological characteristics of SARS-CoV-2 in Africa
April 26, 2021 Jones Lamptey, Favour Oluwapelumi Oyelami, Michael Owusu, Bernard Nkrumah, Paul Oluwagbenga Idowu, Enoch Appiah Adu-Gyamfi, Armin Czika, Philip El-Duah, Richmond Yeboah, Augustina Sylverken, Oluwatayo Israel Olasunkanmi, Ellis Owusu-Dabo, Christian Drosten, Yaw Adu-Sarkodie

Since late 2019, the coronavirus disease 2019 (COVID-19) outbreak, caused by SARS-CoV-2, has rapidly evolved to become a global pandemic.…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases-Rocky Mountain Laboratories, NIH, CC-0 Public Domain

PLOS Neglected Tropical Diseases Distinguishing non severe cases of dengue from COVID-19 in the context of co-epidemics: A cohort study in a SARS-CoV-2 testing center on Reunion island
April 26, 2021 Antoine Joubert, Fanny Andry, Antoine Bertolotti, Frédéric Accot, Yatrika Koumar, Florian Legrand, Patrice Poubeau, Rodolphe Manaquin, Patrick Gérardin, Cécile Levin

Background: As coronavirus 2019 (COVID-19) is spreading globally, several countries are handling dengue epidemics. As both infections are…
Image credit
Fig 1. Number of deaths in 2020 according to age class. by Costantino et al., CC BY 4.0

PLOS ONE Utility of hospitalization for elderly individuals affected by COVID-19
April 26, 2021 Giorgio Costantino, Monica Solbiati, Silvia Elli, Marco Paganuzzi, Didi Massabò, Nicola Montano, Marta Mancarella, Francesca Cortellaro, Emanuela Cataudella, Andrea Bellone, Nicolò Capsoni, Guido Bertolini, Giovanni Nattino, Giovanni Casazza

Background: During the COVID-19 pandemic, the number of individuals needing hospital admission has sometimes exceeded the availability of…
Image credit
Fig 2. Fitted logistic curves of daily COVID-19 infections for Ireland, Germany, UK, South Korea and Iceland. by Wu et al., CC BY 4.0

PLOS ONE Correlation of national and healthcare workers COVID-19 infection data; implications for large-scale viral testing programs
April 23, 2021 Dan Wu, Pól Mac Aonghusa, Donal F. O’Shea

Time analysis of the course of an infectious disease epidemic is a critical way to understand the dynamics of pathogen transmission and…
Image credit
Fig 1. by Derington et al., CC BY 4.0

PLOS ONE Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans
April 23, 2021 Catherine G. Derington, Jordana B. Cohen, April F. Mohanty, Tom H. Greene, James Cook, Jian Ying, Guo Wei, Jennifer S. Herrick, Vanessa W. Stevens, Barbara E. Jones, Libo Wang, Alexander R. Zheutlin, Andrew M. South, Thomas C. Hanff, Steven M. Smith, Rhonda M. Cooper-DeHoff, Jordan B. King, G. Caleb Alexander, Dan R. Berlowitz, Faraz S. Ahmad, M. Jason Penrod, Rachel Hess, Molly B. Conroy, James C. Fang, Michael A. Rubin, Srinivasan Beddhu, Alfred K. Cheung, Weiming Xian, William S. Weintraub, Adam P. Bress

Background: Angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) may positively or negatively…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases-Rocky Mountain Laboratories, NIH, CC-0 Public Domain

PLOS ONE Vertical transmission of Severe Acute Respiratory Syndrome Coronavirus 2: A scoping review
April 22, 2021 Lemi Belay Tolu, Alex Ezeh, Garumma Tolu Feyissa

Introduction: The evidence for vertical transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is not well…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases-Rocky Mountain Laboratories, NIH, CC-0 Public Domain

PLOS ONE Prevalence, clinical features, and outcomes of SARS-CoV-2 infection in pregnant women with or without mild/moderate symptoms: Results from universal screening in a tertiary care center in Mexico City, Mexico
April 22, 2021 J. Arturo Cardona-Pérez, Isabel Villegas-Mota, A. Cecilia Helguera-Repetto, Sandra Acevedo-Gallegos, Mario Rodríguez-Bosch, Mónica Aguinaga-Ríos, Irma Coronado-Zarco, Moisés León-Juárez, Diana Aguilar-Ayala, María Yolotzin Valdespino-Vázquez, Elsa Romelia Moreno-Verduzco, María Antonieta Rivera, Carolina Valencia-Contreras, María de Lourdes Gómez-Sousa, Mario Solis-Paredes, Brenda Frías-Madrid, César Velasco-Téllez, Juan Carlos Rodriguez-Aldama, Valeria Avila-Sosa, Rafael Galván-Contreras, Ricardo Figueroa-Damian, Manuel Cortés-Bonilla, Guadalupe Estrada-Gutierrez, Salvador Espino-y-Sosa, Claudine Irles

The perinatal consequences of SARS-CoV-2 infection are still largely unknown. This study aimed to describe the features and outcomes of…
Image credit
Fig 1. Model flow chart. by Tsoungui Obama et al., CC BY 4.0

PLOS ONE Preventing COVID-19 spread in closed facilities by regular testing of employees—An efficient intervention in long-term care facilities and prisons?
April 22, 2021 Henri Christian Junior Tsoungui Obama, Nessma Adil Mahmoud Yousif, Looli Alawam Nemer, Pierre Marie Ngougoue Ngougoue, Gideon Akumah Ngwa, Miranda Teboh-Ewungkem, Kristan Alexander Schneider

Background: Different levels of control measures were introduced to contain the global COVID-19 pandemic, many of which have been…
Image credit
Fig 1. Seroprevalence of COVID-19 in the military police of Rio Grande do Sul. by Pasqualotto et al., CC BY 4.0

PLOS ONE COVID-19 seroprevalence in military police force, Southern Brazil
April 22, 2021 Alessandro C. Pasqualotto, Paula de Castro Pereira, Daiane F. Dalla Lana, Alexandre V. Schwarzbold, Marco S. Ribeiro, Cezar V. W. Riche, Cristiani Pilati P. Castro, Paula L. Korsack, Paulo Emilio B. Ferreira, Guilherme de C. Domingues, Giorgia T. Ribeiro, Marcelo Carneiro, Cassia Ferreira B. Caurio, Izadora Clezar da S. Vasconcellos, Lidiana M. Knebel, Lucas Zamberlan, Andressa P. Stolz, Macarthur Vilanova, Guilherme Watte, Antonio N. Kalil

Background: Limited data is available regarding the frequency of COVID-19 in populations that are highly exposed to SARS-CoV-2. In this…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases-Rocky Mountain Laboratories, NIH, CC-0 Public Domain

PLOS ONE SARS-CoV-2 testing strategy: A comparison of restricted and extended strategies in a Swiss outpatient cohort from the community and hospital employees
April 22, 2021 Stéphanie Baggio, Hervé Spechbach, Nathalie Vernaz, Idris Guessous, Laurent Gétaz, Laurent Kaiser, François Chappuis, Julien Salamun, Frédérique Jacquerioz

Background: Testing is a key measure to control the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we…
Image credit
Fig 2. Groups of susceptible and immunized individuals. by Adil Mahmoud Yousif et al., CC BY 4.0

PLOS ONE The impact of COVID-19 vaccination campaigns accounting for antibody-dependent enhancement
April 22, 2021 Nessma Adil Mahmoud Yousif, Henri Christian Junior Tsoungui Obama, Yvan Jordan Ngucho Mbeutchou, Sandy Frank Kwamou Ngaha, Loyce Kayanula, George Kamanga, Toheeb Babatunde Ibrahim, Patience Bwanu Iliya, Sulyman Iyanda, Looli Alawam Nemer, Kristina Barbara Helle, Miranda Ijang Teboh-Ewungkem, Kristan Alexander Schneider

Background: COVID-19 vaccines are approved, vaccination campaigns are launched, and worldwide return to normality seems within close reach.…
Image credit
Fig 3. Screening cascade for the progression of hit molecules. by Choi et al., CC BY 4.0

PLOS ONE High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity
April 22, 2021 Ryan Choi, Mowei Zhou, Roger Shek, Jesse W. Wilson, Logan Tillery, Justin K. Craig, Indraneel A. Salukhe, Sarah E. Hickson, Neeraj Kumar, Rhema M. James, Garry W. Buchko, Ruilian Wu, Sydney Huff, Tu-Trinh Nguyen, Brett L. Hurst, Sara Cherry, Lynn K. Barrett, Jennifer L. Hyde, Wesley C. Van Voorhis

SARS-CoV-2 has caused a global pandemic, and has taken over 1.7 million lives as of mid-December, 2020. Although great progress has been…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID/NIH, CC-0 Public Domain

PLOS ONE Clinical characteristics and outcomes of patients with Corona Virus Disease 2019 (COVID-19) at Mercy Health Hospitals, Toledo, Ohio
April 22, 2021 Muhammad Shayan Khan, Ratika Dogra, Leela K. V. Miriyala, F. N. U. Salman, Rizwan Ishtiaq, Dilnoor K. Patti, Aakash Kumar, Gaurav Sandho, Karim Jacob, Kritika Luthra, Ravina Sharma, Rekha Ravikumar, Dharmakaruna Edara, Shanti Pittampalli, Divya Sood, Vinod Khatri, Vijay Mahajan, Salil Avasthi, Arlette Auoad, Srinivas Katragadda

Importance: The ongoing pandemic of the novel Corona Virus Disease 2019 (COVID-19) is an unprecedented challenge to global health, never…
Image credit
Untitled by Moghadas et al., CC BY 4.0

PLOS Biology Evaluation of COVID-19 vaccination strategies with a delayed second dose
April 21, 2021 Seyed M. Moghadas, Thomas N. Vilches, Kevin Zhang, Shokoofeh Nourbakhsh, Pratha Sah, Meagan C. Fitzpatrick, Alison P. Galvani

Two of the Coronavirus Disease 2019 (COVID-19) vaccines currently approved in the United States require 2 doses, administered 3 to 4 weeks…
Image credit
Fig 1. Flowchart of the article screening and selection process. by Wang et al., CC BY 4.0

PLOS ONE The proportion and effect of corticosteroid therapy in patients with COVID-19 infection: A systematic review and meta-analysis
April 21, 2021 Junning Wang, Weixia Yang, Puwen Chen, Jianbin Guo, Rui Liu, Pengfei Wen, Kun Li, Yao Lu, Tao Ma, Xiaoli Li, Siqing Qin, Yumin Zhang, Yakang Wang

Objectives: Coronavirus disease 2019 (COVID-19) remains a global challenge. Corticosteroids constitute a group of anti-inflammatory and…
Image credit
Fig 2. Chest radiographs (CXRs) of an initially asymptomatic patient. by Kim et al., CC BY 4.0

PLOS ONE COVID-19 infection with asymptomatic or mild disease severity in young patients: Clinical course and association between prevalence of pneumonia and viral load
April 21, 2021 Cherry Kim, Wooil Kim, Ji Hoon Jeon, Hyeri Seok, Sun Bean Kim, Hee Kyoung Choi, Young Kyung Yoon, Joon Young Song, Dae Won Park, Jang Wook Sohn, Won Suk Choi

Few studies have focused on clinical courses or viral loads in young asymptomatic or mild patients with COVID-19 infection. We sought to…
Image credit
Fig 1. Basic reproductive number (R₀) estimates across United States counties. by Sy et al., CC BY 4.0

PLOS ONE Population density and basic reproductive number of COVID-19 across United States counties
April 21, 2021 Karla Therese L. Sy, Laura F. White, Brooke E. Nichols

The basic reproductive number (R0) is a function of contact rates among individuals, transmission probability, and duration of…
Image credit
Fig 2. Plot dispersion of Perme Mobility Index (PMI)–ΔPerme Score and the ICU LOS of each included patient (open circle represents patients under 60 years of age and closed circle represents patients above or equal 60 years of age). by Timenetsky et al., CC BY 4.0

PLOS ONE The Perme Mobility Index: A new concept to assess mobility level in patients with coronavirus (COVID-19) infection
April 21, 2021 Karina Tavares Timenetsky, Ary Serpa Neto, Ana Carolina Lazarin, Andreia Pardini, Carla Regina Sousa Moreira, Thiago Domingos Corrêa, Raquel Afonso Caserta Eid, Ricardo Kenji Nawa

Introduction: The Coronavirus Disease 2019 (COVID-19) outbreak is evolving rapidly worldwide. Data on the mobility level of patients with…
Image credit
Fig 1. Epidemic curve showing cases of COVID-19 in Blaine County, Idaho residents by date of illness onset (n = 447). by Dunne et al., CC BY 4.0

PLOS ONE Investigation and public health response to a COVID-19 outbreak in a rural resort community—Blaine County, Idaho, 2020
April 21, 2021 Eileen M. Dunne, Tanis Maxwell, Christina Dawson-Skuza, Matthew Burns, Christopher Ball, Kathryn Turner, Christine G. Hahn, Melody Bowyer, Kris K. Carter, Logan Hudson

Blaine County, Idaho, a rural area with a renowned resort, experienced a COVID-19 outbreak early in the pandemic. We undertook an…
Image credit
Fig 1. Research framework of the study. by Ramatillah and Isnaini, CC BY 4.0

PLOS ONE Treatment profiles and clinical outcomes of COVID-19 patients at private hospital in Jakarta
April 16, 2021 Diana Laila Ramatillah, Suri Isnaini

Background: Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a virus that causes COVID-19, which has become a worldwide…
Image credit
Fig 1. by Doghish et al., CC BY 4.0

PLOS ONE Clinical characteristics of Egyptian male patients with COVID‐19 acute respiratory distress syndrome
April 16, 2021 Ahmed S. Doghish, Walid F. Elkhatib, Essam A. Hassan, Ahmed F. Elkhateeb, Eman E. Mahmoud, Mona I. Ahmed, Mahmoud A. F. Khalil

Background: Coronavirus disease 2019 (COVID-19) is a serious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…
Image credit
Fig 1. Flow cytometric analysis of peripheral blood NK cell subsets and receptors in COVID-19 patients. by Bozzano et al., CC BY 4.0

PLOS Pathogens Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity
April 16, 2021 Federica Bozzano, Chiara Dentone, Carola Perrone, Antonio Di Biagio, Daniela Fenoglio, Alessia Parodi, Malgorzata Mikulska, Bianca Bruzzone, Daniele Roberto Giacobbe, Antonio Vena, Lucia Taramasso, Laura Nicolini, Nicolò Patroniti, Paolo Pelosi, Angelo Gratarola, Raffaele De Palma, Gilberto Filaci, Matteo Bassetti, Andrea De Maria, on behalf of GECOVID study group

The SARS-CoV-2 infection causes severe respiratory involvement (COVID-19) in 5–20% of patients through initial immune derangement,…
Image credit
Fig 1. Epidemiological description of SARS-CoV-2 in the Colombian Amazonas department. by Ballestros et al., CC BY 4.0

PLOS Neglected Tropical Diseases Deciphering the introduction and transmission of SARS-CoV-2 in the Colombian Amazon Basin
April 15, 2021 Nathalia Ballesteros, Marina Muñoz, Luz Helena Patiño, Carolina Hernández, Felipe González-Casabianca, Iván Carroll, Mauricio Santos-Vega, Jaime Cascante, Andrés Angel, Alejandro Feged-Rivadeneira, Mónica Palma-Cuero, Carolina Flórez, Sergio Gomez, Adriana van de Guchte, Zenab Khan, Jayeeta Dutta, Ajay Obla, Hala Alejel Alshammary, Ana S. Gonzalez-Reiche, Matthew M. Hernandez, Emilia Mia Sordillo, Viviana Simon, Harm van Bakel, Alberto Paniz-M, Juan David Ramírez

Background: The SARS-CoV-2 pandemic has forced health authorities across the world to take important decisions to curtail its spread.…
Image credit
Fig 1. Epidemiologic curve of persons under investigation for COVID-19: Frequency by determination date, SARS-CoV-2 test status, and COVID-19 case type, United States, January 17–February 29, 2020 (N = 711). by McGovern et al., CC BY 4.0

PLOS ONE Demographic, clinical, and epidemiologic characteristics of persons under investigation for Coronavirus Disease 2019—United States, January 17–February 29, 2020
April 15, 2021 Olivia L. McGovern, Mark Stenger, Sara E. Oliver, Tara C. Anderson, Cheryl Isenhour, Matthew R. Mauldin, Nia Williams, Eric Griggs, Tonny Bogere, Chris Edens, Aaron T. Curns, Joana Y. Lively, Yingtao Zhou, Songli Xu, Maureen H. Diaz, Jessica L. Waller, Kevin R. Clarke, Mary E. Evans, Elisabeth M. Hesse, Sapna Bamrah Morris, Robert P. McClung, Laura A. Cooley, Naeemah Logan, Andrew T. Boyd, Allan W. Taylor, Kristina L. Bajema, Stephen Lindstrom, Christopher A. Elkins, Christopher Jones, Aron J. Hall, Samuel Graitcer, Alexandra M. Oster, Alicia M. Fry, Marc Fischer, Laura Conklin, Runa H. Gokhale

Background: The Coronavirus Disease 2019 (COVID-19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, CC-0 Public Domain

PLOS ONE A qualitative study of the first batch of medical assistance team’s first-hand experience in supporting the nursing homes in Wuhan against COVID-19
April 15, 2021 Xiu-Fen Yang, Meng-qi Li, Lu-lu Liao, Hui Feng, Si Zhao, Shuang Wu, Ping Yin

Background: The pandemic of coronavirus disease 2019 (COVID-19) has global impact, Wuhan in Hubei province is a high-risk area. And the…
Image credit
Fig 2. Serum albumin concentrations among patients with and without SARS-CoV-2 antibodies in July 2020. by Anand et al., CC BY 4.0

PLOS ONE Laboratory correlates of SARS-CoV-2 seropositivity in a nationwide sample of patients on dialysis in the U.S.
April 15, 2021 Shuchi Anand, Maria E. Montez-Rath, Jialin Han, Pablo Garcia, Julie Bozeman, Russell Kerschmann, Paul Beyer, Julie Parsonnet, Glenn M. Chertow

Patients on dialysis are at high risk for death due to COVID-19, yet a significant proportion do survive as evidenced by presence of…
Image credit
Fig 3. Serum I-FABP correlated with the number of polymorphonuclear cells in COVID-19 patients. by Guedj et al., CC BY 4.0

PLOS ONE I-FABP is decreased in COVID-19 patients, independently of the prognosis
April 15, 2021 Kevin Guedj, Mathieu Uzzan, Damien Soudan, Catherine Trichet, Antonino Nicoletti, Emmanuel Weiss, Hana Manceau, Alexandre Nuzzo, Olivier Corcos, Xavier Treton, Katell Peoc’h

Background: Severe acute respiratory syndrome caused by the novel coronavirus (SARS-CoV-2) is frequently associated with gastrointestinal…
Image credit
Fig 4. Use of the Biomark-based protocol to detect mutations associated with SARS-CoV-2 variants. by JFassy et al., CC BY 4.0

PLOS ONE Versatile and flexible microfluidic qPCR test for high-throughput SARS-CoV-2 and cellular response detection in nasopharyngeal swab samples
April 14, 2021 Julien Fassy, Caroline Lacoux, Sylvie Leroy, Latifa Noussair, Sylvain Hubac, Aurélien Degoutte, Georges Vassaux, Vianney Leclercq, David Rouquié, Charles-Hugo Marquette, Martin Rottman, Patrick Touron, Antoinette Lemoine, Jean-Louis Herrmann, Pascal Barbry, Jean-Louis Nahon, Laure-Emmanuelle Zaragosi, Bernard Mari

The emergence and quick spread of SARS-CoV-2 has pointed at a low capacity response for testing large populations in many countries, in…
Image credit
Fig 1. by Ravindra et al., CC BY 4.0

PLOS ONE Impact of COVID-19 on the hospitalization, treatment, and outcomes of intracerebral and subarachnoid hemorrhage in the United States
April 14, 2021 Vijay M. Ravindra, Ramesh Grandhi, Alen Delic, Samuel Hohmann, Ernie Shippey, David Tirschwell, Jennifer A. Frontera, Shadi Yaghi, Jennifer J. Majersik, Mohammad Anadani, Adam de Havenon

Objective: To examine the outcomes of adult patients with spontaneous intracranial and subarachnoid hemorrhage diagnosed with comorbid…
Image credit
Fig 1. Proportion of states with high COVID-19 rates among those in the low and high mask adherence quartiles in the preceding month. by Fischer et al., CC BY 4.0

PLOS ONE Mask adherence and rate of COVID-19 across the United States
April 14, 2021 Charlie B. Fischer, Nedghie Adrien, Jeremiah J. Silguero, Julianne J. Hopper, Abir I. Chowdhury, Martha M. Werler

Mask wearing has been advocated by public health officials as a way to reduce the spread of COVID-19. In the United States, policies on…
Image credit
Fig 2. Close up of port on scent wheel. by Essler et al., CC BY 4.0

PLOS ONE Discrimination of SARS-CoV-2 infected patient samples by detection dogs: A proof of concept study
April 14, 2021 Jennifer L. Essler, Sarah A. Kane, Pat Nolan, Elikplim H. Akaho, Amalia Z. Berna, Annemarie DeAngelo, Richard A. Berk, Patricia Kaynaroglu, Victoria L. Plymouth, Ian D. Frank, Susan R. Weiss, Audrey R. Odom John, Cynthia M. Otto

While the world awaits a widely available COVID-19 vaccine, availability of testing is limited in many regions and can be further…
Image credit
Novel Coronavirus SARS-Cov-2 by NIAID, CC-0 Public Domain

PLOS ONE Low risk of SARS-CoV-2 in blood transfusion
April 13, 2021 Michael Owusu, Augustina Angelina Sylverken, Philip El-Duah, Nana Kwame Ayisi-Boateng, Richmond Yeboah, Eric Adu, Jesse Asamoah, Michael Frimpong, Japhet Senyo, Godfred Acheampong, Mohamed Mutocheluh, John Amuasi, Ellis Owusu-Dabo, Yaw Adu-Sarkodie, Richard Odame Phillips

Background: The novel coronavirus disease (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2),…
Image credit
Fig 1. Viral copies and Ct values in mask and NPS samples. by Sriraman et al., CC BY 4.0

PLOS ONE Non-invasive adapted N-95 mask sampling captures variation in viral particles expelled by COVID-19 patients: Implications in understanding SARS-CoV2 transmission
April 12, 2021 Kalpana Sriraman, Ambreen Shaikh, Swapneil Parikh, Shreevatsa Udupa, Nirjhar Chatterjee, Jayanthi Shastri, Nerges Mistry

Infectious respiratory particles expelled by SARS-CoV-2 positive patients are attributed to be the key driver of COVID-19 transmission.…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID/NIH, CC-0 Public Domain

PLOS ONE Knowledge, preventive behaviors and risk perception of the COVID-19 pandemic: A cross-sectional study in Turkish health care workers
April 9, 2021 Tufan Arslanca, Cihan Fidan, Mine Daggez, Polat Dursun

The coronavirus disease 2019 (COVID-19) outbreak spread to over 100 countries with a total of 100,000 cases during the first week of March…
Image credit
Fig 2. by Rasmussen et al., CC BY 4.0

PLOS ONE SARS-CoV-2 infection dynamics in Denmark, February through October 2020: Nature of the past epidemic and how it may develop in the future
April 9, 2021 Steen Rasmussen, Michael Skytte Petersen, Niels Høiby

Background: Initially, the relative sizes of the asymptomatic and the symptomatic infected populations were not known for the COVID-19…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID/NIH, CC-0 Public Domain

PLOS ONE Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy
April 8, 2021 Juan Macías, Paz González-Moreno, Esther Sánchez-García, Ramón Morillo-Verdugo, José J. Pérez-Venegas, Ana Pinilla, MªMar Macho, MªVictoria Martínez, Alejandro González-Serna, Anaïs Corma, Luis M. Real, Juan A. Pineda

Background: Hydroxychloroquine is not efficacious as post-exposure prophylaxis against coronavirus disease 2019 (COVID-19). It is not known…
Image credit
Fig 2. Distribution of ordinal scale on day one, prior to treatment, day 14, and day 28. by Mehta et al., CC BY 4.0

PLOS ONE What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak
April 8, 2021 Monica Mehta, Lawrence J. Purpura, Thomas H. McConville, Matthew J. Neidell, Michaela R. Anderson, Elana J. Bernstein, Donald E. Dietz, Justin Laracy, Shauna H. Gunaratne, Emily Happy Miller, Jennifer Cheng, Jason Zucker, Shivang S. Shah, Shaoli Chaudhuri, Christian A. Gordillo, Shreena R. Patel, Tai Wei Guo, Lara E. Karaaslan, Ran Reshef, Benjamin A. Miko, Joan M. Bathon, Marcus R. Pereira, Anne-Catrin Uhlemann, Michael T. Yin, Magdalena E. Sobieszczyk

Background: Tocilizumab, an interleukin-6 receptor blocker, has been used in the inflammatory phase of COVID-19, but its impact independent…
Image credit
Fig 1. Map of a portion of the underground sewer pipeline network of Belmont, Massachusetts (thanks to PeopleGIS for granting permission to publish this MapsOnline site.). by Nourinejad et al., CC BY 4.0

PLOS ONE Placing sensors in sewer networks: A system to pinpoint new cases of coronavirus
April 8, 2021 Mehdi Nourinejad, Oded Berman, Richard C. Larson

We consider a proposed system that would place sensors in a number of wastewater manholes in a community in order to detect genetic…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases, NIH, CC-0 Public Domain

PLOS ONE Prevalence of SARS-COV-2 positivity in 516 German intensive care and emergency physicians studied by seroprevalence of antibodies National Covid Survey Germany (NAT-COV-SURV)
April 8, 2021 Detlef Kindgen-Milles, Timo Brandenburger, Julian F. W. Braun, Corvin Cleff, Kian Moussazadeh, Ingo Mrosewski, Jörg Timm, Dietmar Wetzchewald

Healthcare personnel are at risk to aquire the corona virus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome…
Image credit
Fig 1. Days from admission to the appearance of neurologic events. by Flores-Silva et al., CC BY 4.0

PLOS ONE Neurologic manifestations in hospitalized patients with COVID-19 in Mexico City
April 8, 2021 Fernando Daniel Flores-Silva, Miguel García-Grimshaw, Sergio Iván Valdés-Ferrer, Alma Poema Vigueras-Hernández, Rogelio Domínguez-Moreno, Dioselina Panamá Tristán-Samaniego, Anaclara Michel-Chávez, Alejandra González-Duarte, Felipe A. Vega-Boada, Isael Reyes-Melo, Amado Jiménez-Ruiz, Oswaldo Alan Chávez-Martínez, Daniel Rebolledo-García, Osvaldo Alexis Marché-Fernández, Samantha Sánchez-Torres, Guillermo García-Ramos, Carlos Cantú-Brito, Erwin Chiquete

Background: The coronavirus disease 2019 (COVID-19) is a systemic entity that frequently implies neurologic features at presentation and…
Image credit
Fig 2. Antigen kinetics determined for specimens from 38 COVID-19 patients at different post-symptom-onset periods assessed by two antigen assays according to cut-off index values, the AFIAS COVID-19 Ag and the ichroma^TM COVID-19 Ag. by Kweon et al., CC BY 4.0

PLOS ONE Evaluation of rapid SARS-CoV-2 antigen tests, AFIAS COVID-19 Ag and ichroma COVID-19 Ag, with serial nasopharyngeal specimens from COVID-19 patients
April 8, 2021 Oh Joo Kweon, Yong Kwan Lim, Hye Ryoun Kim, Yoojeong Choi, Min-Chul Kim, Seong-Ho Choi, Jin-Won Chung, Mi-Kyung Lee

We evaluated the diagnostic accuracy of two newly developed, point-of-care, rapid antigen tests (RATs) for detecting SARS-CoV-2, the AFIAS…
Image credit
Fig 2. Comparison of COVID-19 and post-COVID-19 symptoms. by Mahmud et al., CC BY 4.0

PLOS ONE Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh
April 8, 2021 Reaz Mahmud, Md. Mujibur Rahman, Mohammad Aftab Rassel, Farhana Binte Monayem, S. K. Jakaria Been Sayeed, Md. Shahidul Islam, Mohammed Monirul Islam

Background: Post-coronavirus disease (COVID-19) syndrome includes persistence of symptoms beyond viral clearance and fresh development of…
Image credit
Fig 1. Comparative assessment of 168 serum samples from SARS-CoV-2-infected individuals by ELISA and lateral flow immunoassay. by Sweeney et al., CC BY 4.0

PLOS ONE Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic wave
April 7, 2021 Nicola Sweeney, Blair Merrick, Rui Pedro Galão, Suzanne Pickering, Alina Botgros, Harry D. Wilson, Adrian W. Signell, Gilberto Betancor, Mark Kia Ik Tan, John Ramble, Neophytos Kouphou, Sam Acors, Carl Graham, Jeffrey Seow, Eithne MacMahon, Stuart J. D. Neil, Michael H. Malim, Katie Doores, Sam Douthwaite, Rahul Batra, Gaia Nebbia, Jonathan D. Edgeworth

During the first wave of the global COVID-19 pandemic the clinical utility and indications for SARS-CoV-2 serological testing were not…
Image credit
Fig 1. Odd ratio of A (red square) and O group (green circle) from our study and the ones found in the literature. by Muñoz-Culla et al., CC BY 4.0

PLOS ONE O group is a protective factor for COVID19 in Basque population
April 7, 2021 Maider Muñoz-Culla, Andres Roncancio-Clavijo, Bruno Martínez, Miriam Gorostidi-Aicua, Luis Piñeiro, Arkaitz Azkune, Ainhoa Alberro, Jorge Monge-Ruiz, Tamara Castillo-Trivino, Alvaro Prada, David Otaegui

ABO blood groups have recently been related to COVID19 infection. In the present work, we performed this analysis using data from 412…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID-RML, CC-0 Public Domain

PLOS ONE Association of ABO blood groups with presentation and outcomes of confirmed SARS CoV-2 infection: A prospective study in the largest COVID-19 dedicated hospital in Bangladesh
April 7, 2021 Reaz Mahmud, Mohammad Aftab Rassel, Farhana Binte Monayem, S. K. Jakaria Been Sayeed, Md Shahidul Islam, Mohammed Monirul Islam, Mohammad Abdullah Yusuf, Sabrina Rahman, K. M. Nazmul Islam, Imran Mahmud, Mohammad Zaid Hossain, Ahmed Hossain Chowdhury, A. K. M. Humayon Kabir, Kazi Gias Uddin Ahmed, Md. Mujibur Rahman

Background: Globally, studies have shown conflicting results regarding the association of blood groups with SARS CoV-2 infection.…
Image credit
Fig 3. SARS-CoV-2 intrahost single nucleotide variant (iSNV) diversity. by Valesano et al., CC BY 4.0

PLOS Pathogens Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts
April 7, 2021 Andrew L. Valesano, Kalee E. Rumfelt, Derek E. Dimcheff, Christopher N. Blair, William J. Fitzsimmons, Joshua G. Petrie, Emily T. Martin, Adam S. Lauring

Analysis of SARS-CoV-2 genetic diversity within infected hosts can provide insight into the generation and spread of new viral variants…
Image credit
Fig 7. Galbraith plot identified eight outlier studies as potential sources of heterogeneity. by Islam et al., CC BY 4.0

PLOS ONE Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 patients
April 6, 2021 Md Asiful Islam, Shoumik Kundu, Sayeda Sadia Alam, Tareq Hossan, Mohammad Amjad Kamal, Rosline Hassan

Background: Coronavirus disease 2019 (COVID-19), a pandemic disease caused by the severe acute respiratory syndrome coronavirus 2 started…
Image credit
Fig 1. Seroprevalence of antibodies to SARS-CoV-2. by Hiki et al., CC BY 4.0

PLOS ONE Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients
April 6, 2021 Makoto Hiki, Yoko Tabe, Tomohiko Ai, Yuya Matsue, Norihiro Harada, Kiichi Sugimoto, Yasushi Matsushita, Masakazu Matsushita, Mitsuru Wakita, Shigeki Misawa, Mayumi Idei, Takashi Miida, Naoto Tamura, Kazuhisa Takahashi, Toshio Naito

Objectives: To determine the seroprevalence of anti-SARS-CoV-2 IgG and IgM antibodies in symptomatic Japanese COVID-19 patients. Methods:…
Image credit
Fig 1. Correlation between IL-6 and NLR. by Garcia-Gordillo et al., CC BY 4.0

PLOS ONE COVID-IRS: A novel predictive score for risk of invasive mechanical ventilation in patients with COVID-19
April 5, 2021 José Antonio Garcia-Gordillo, Antonio Camiro-Zúñiga, Mercedes Aguilar-Soto, Dalia Cuenca, Arturo Cadena-Fernández, Latife Salame Khouri, Jesica Naanous Rayek, Moises Mercado, The ARMII Study Group

Background: Coronavirus disease 2019 (COVID-19) is a systemic disease that can rapidly progress into acute respiratory failure and death.…
Image credit
Fig 1. Kaplan-Meier curves for cumulative survival probability during hospitalization. by He et al., CC BY 4.0

PLOS ONE Clinical characteristics of COVID-19 patients with clinically diagnosed bacterial co-infection: A multi-center study
April 5, 2021 Shengyang He, Wenlong Liu, Mingyan Jiang, Peng Huang, Zhi Xiang, Dingding Deng, Ping Chen, Lihua Xie

Objective: To understand the clinical characteristics of COVID-19 patients with clinically diagnosed bacterial co-infection (CDBC), and…
Image credit
Fig 2. The average Ct value of E, RdRP and ORF 1ab gene in different clinical samples. by Sharma et al., CC BY 4.0

PLOS ONE Comparative analysis of various clinical specimens in detection of SARS-CoV-2 using rRT-PCR in new and follow up cases of COVID-19 infection: Quest for the best choice
April 5, 2021 Kuldeep Sharma, Pragya Aggarwala, Deepa Gandhi, Anuniti Mathias, Priyanka Singh, Somya Sharma, Sanjay Singh Negi, Anudita Bhargava, Padma Das, Ujjwala Gaikwad, Archana Wankhede, Ajoy Behra, Nitin M. Nagarkar

Background: An appropriate specimen is of paramount importance in Real Time reverse transcription-polymerase chain reaction (rRT-PCR) based…
Image credit
Novel Coronavirus SARS-CoV-2 by NIAID-RML, CC-0 Public Domain

PLOS ONE Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: Implications for screening in a school setting
April 5, 2021 Neeraj Sood, Rashmi Shetgiri, Anna Rodriguez, Dianna Jimenez, Sonia Treminino, Amanda Daflos, Paul Simon

Background: Rapid antigen tests hold much promise for use in the school environment. However, the performance of these tests in…
Image credit
Fig 2. Log-log plot of study seroprevalence (x-axis) vs two cumulative case estimators for each study. by Byambasuren et al., CC BY 4.0

PLOS ONE Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19 cases: Systematic review
April 2, 2021 Oyungerel Byambasuren, Claudia C. Dobler, Katy Bell, Diana Patricia Rojas, Justin Clark, Mary-Louise McLaws, Paul Glasziou

Background: Accurate seroprevalence estimates of SARS-CoV-2 in different populations could clarify the extent to which current testing…
Image credit
Fig 1. Daily cumulative number of first reported case COVID-19 and school closure. by Nazif-Muñoz et al., CC BY 4.0

PLOS ONE The global viralization of policies to contain the spreading of the COVID-19 pandemic: Analyses of school closures and first reported cases
April 1, 2021 José Ignacio Nazif-Muñoz, Sebastián Peña, Youssef Oulhote

Background: On January 30th 2020, the World Health Organization (WHO) declared a international health emergency due to the unprecedented…
Image credit
Fig 1. Numbers of confirmed COVID-19 cases across geographical areas of Thailand as of July 4, 2020. by Nopsopon et al., CC BY 4.0

PLOS ONE Seroprevalence of hospital staff in a province with zero COVID-19 cases
April 1, 2021 Tanawin Nopsopon, Krit Pongpirul, Korn Chotirosniramit, Wutichai Jakaew, Chuenkhwan Kaewwijit, Sawan Kanchana, Narin Hiransuthikul

Background: COVID-19 seroprevalence data, particularly in less developed countries with a relatively low incidence, has been scant. We…
Image credit
Fig 1. Ranking of counties based on health indicators. by Bhowmik et al., CC BY 4.0

PLOS ONE A comprehensive analysis of COVID-19 transmission and mortality rates at the county level in the United States considering socio-demographics, health indicators, mobility trends and health care infrastructure attributes
April 1, 2021 Tanmoy Bhowmik, Sudipta Dey Tirtha, Naveen Chandra Iraganaboina, Naveen Eluru

Background: Several research efforts have evaluated the impact of various factors including a) socio-demographics, (b) health indicators,…
Image credit
Fig 2. COVID-19 outbreak examples. by Gros et al., CC BY 4.0

PLOS ONE Predicting the cumulative medical load of COVID-19 outbreaks after the peak in daily fatalities
April 1, 2021 Claudius Gros, Roser Valenti, Lukas Schneider, Benedikt Gutsche, Dimitrije Marković

The distinct ways the COVID-19 pandemic has been unfolding in different countries and regions suggest that local societal and governmental…
Image credit
Fig 1. Overview of the proposed diagnostic system for COVID-19. by Han et al., CC BY 4.0

PLOS ONE Semi-supervised learning for an improved diagnosis of COVID-19 in CT images
April 1, 2021 Chang Hee Han, Misuk Kim, Jin Tae Kwak

Coronavirus disease 2019 (COVID-19) has been spread out all over the world. Although a real-time reverse-transcription polymerase chain…
Image credit
Fig 1. A weekly timeline of the COVID-19 epidemic. by Kasztelewicz et al., CC BY 4.0

PLOS ONE Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland
April 1, 2021 Beata Kasztelewicz, Katarzyna Janiszewska, Julia Burzyńska, Emilia Szydłowska, Marek Migdał, Katarzyna Dzierżanowska-Fangrat

Data on the prevalence of the SARS-CoV-2 antibody in healthcare workers (HCWs) is scarce, especially in pediatric settings. The purpose of…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases-Rocky Mountain Laboratories, NIH, CC-0 Public Domain

PLOS ONE Baseline cardiometabolic profiles and SARS-CoV-2 infection in the UK Biobank
April 1, 2021 Ryan J. Scalsky, Yi-Ju Chen, Karan Desai, Jeffery R. O’Connell, James A. Perry, Charles C. Hong

Background: SARS-CoV-2 is a rapidly spreading coronavirus responsible for the Covid-19 pandemic, which is characterized by severe…
Image credit
Fig 1. ROC curves mechanical ventilation prediction (AUC 68%). by Yu et al., CC BY 4.0

PLOS ONE Machine learning methods to predict mechanical ventilation and mortality in patients with COVID-19
April 1, 2021 Limin Yu, Alexandra Halalau, Bhavinkumar Dalal, Amr E. Abbas, Felicia Ivascu, Mitual Amin, Girish B. Nair

Background: The Coronavirus disease 2019 (COVID-19) pandemic has affected millions of people across the globe. It is associated with a high…
Image credit
Fig 1. Map showing all health facilities in Bulawayo district and highlighting the 24 sampled health facilities. by Rusakaniko et al., CC BY 4.0

PLOS Neglected Tropical Diseases SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe
March 31, 2021 Simbarashe Rusakaniko, Elopy Nemele Sibanda, Takafira Mduluza, Paradzayi Tagwireyi, Zephaniah Dhlamini, Chiratidzo Ellen Ndhlovu, Precious Chandiwana, Shingirai Chiwambutsa, Rivka May Lim, Fiona Scott, Lindiwe Majele Sibanda, Francisca Mutapi

Background: In order to protect health workers from SARS-CoV-2, there is need to characterise the different types of patient facing health…
Image credit
Fig 1. Number of COVID-19 hospitalizations in Belgium (BE) and the Netherlands (NL) including an overview of the national preventive measures taken during first epidemic wave, February-July 2020. by Verberk et al., CC BY 4.0

PLOS ONE Experiences and needs of persons living with a household member infected with SARS-CoV-2: A mixed method study
March 31, 2021 Janneke D. M. Verberk, Sibyl A. Anthierens, Sarah Tonkin-Crine, Herman Goossens, John Kinsman, Marieke L. A. de Hoog, Julia A. Bielicki, Patricia C. J. L. Bruijning-Verhagen, Nina H. Gobat

Background: Households are important sites for transmission of SARS-CoV-2 and preventive measures are recommended. This study aimed to 1)…
Image credit
Fig 1. Score plot: PC2 vs. PC1. by Lusczek et al., CC BY 4.0

PLOS ONE Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles
March 31, 2021 Elizabeth R. Lusczek, Nicholas E. Ingraham, Basil S. Karam, Jennifer Proper, Lianne Siegel, Erika S. Helgeson, Sahar Lotfi-Emran, Emily J. Zolfaghari, Emma Jones, Michael G. Usher, Jeffrey G. Chipman, R. Adams Dudley, Bradley Benson, Genevieve B. Melton, Anthony Charles, Monica I. Lupei, Christopher J. Tignanelli

Purpose: Heterogeneity has been observed in outcomes of hospitalized patients with coronavirus disease 2019 (COVID-19). Identification of…
Image credit
Fig 1. Study model. by Feldman et al., CC BY 4.0

PLOS ONE Endotracheal intubation of COVID-19 patients by paramedics using a box barrier: A randomized crossover manikin study
March 31, 2021 Oren Feldman, Nir Samuel, Noa Kvatinsky, Ravit Idelman, Raz Diamand, Itai Shavit

Background: In the prehospital setting, endotracheal intubation (ETI) may be required to secure the coronavirus disease 2019 (COVID-19)…
Image credit
Fig 4. Sunburst diagram of medication pathways with individual regimens grouped by order of initiation. by McPadden et al., CC BY 4.0

PLOS ONE Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection
March 31, 2021 Jacob McPadden, Frederick Warner, H. Patrick Young, Nathan C. Hurley, Rebecca A. Pulk, Avinainder Singh, Thomas J. S. Durant, Guannan Gong, Nihar Desai, Adrian Haimovich, Richard Andrew Taylor, Murat Gunel, Charles S. Dela Cruz, Shelli F. Farhadian, Jonathan Siner, Merceditas Villanueva, Keith Churchwell, Allen Hsiao, Charles J. Torre Jr, Eric J. Velazquez, Roy S. Herbst, Akiko Iwasaki, Albert I. Ko, Bobak J. Mortazavi, Harlan M. Krumholz, Wade L. Schulz

Objective: Severe acute respiratory syndrome virus (SARS-CoV-2) has infected millions of people worldwide. Our goal was to identify risk…
Image credit
Fig 2. Distribution by age intervals of the patients admitted for COVID-19 during the first and second waves. by Iftimie et al., CC BY 4.0

PLOS ONE First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain
March 31, 2021 Simona Iftimie, Ana F. López-Azcona, Immaculada Vallverdú, Salvador Hernández-Flix, Gabriel de Febrer, Sandra Parra, Anna Hernández-Aguilera, Francesc Riu, Jorge Joven, Natàlia Andreychuk, Gerard Baiges-Gaya, Frederic Ballester, Marc Benavent, José Burdeos, Alba Català, Èric Castañé, Helena Castañé, Josep Colom, Mireia Feliu, Xavier Gabaldó, Diana Garrido, Pedro Garrido, Joan Gil, Paloma Guelbenzu, Carolina Lozano, Francesc Marimon, Pedro Pardo, Isabel Pujol, Antoni Rabassa, Laia Revuelta, Marta Ríos, Neus Rius-Gordillo, Elisabet Rodríguez-Tomàs, Wojciech Rojewski, Esther Roquer-Fanlo, Noèlia Sabaté, Anna Teixidó, Carlos Vasco, Jordi Camps, Antoni Castro

Many countries have seen a two-wave pattern in reported cases of coronavirus disease-19 during the 2020 pandemic, with a first wave during…
Image credit
Novel Coronavirus SARS-CoV-2 by National Institute of Allergy and Infectious Diseases-Rocky Mountain Laboratories, NIH, CC BY 4.0

PLOS ONE Functional outcomes in the inpatient rehabilitation setting following severe COVID-19 infection
March 31, 2021 Cameron Spencer Olezene, Elizabeth Hansen, Hannah K. Steere, Joseph T. Giacino, Ginger R. Polich, Joanne Borg-Stein, Ross D. Zafonte, Jeffrey C. Schneider

Objective: To characterize the functional impairments of a cohort of patients undergoing inpatient rehabilitation after surviving severe…
Image credit
Untitled by Inbaraj et al., CC BY 4.0

PLOS ONE Seroprevalence of COVID-19 infection in a rural district of South India: A population-based seroepidemiological study
March 31, 2021 Leeberk Raja Inbaraj, Carolin Elizabeth George, Sindhulina Chandrasingh

Objectives: We aimed to estimate the seroprevalence of COVID-19 in a rural district of South India, six months after the index case.…
Image credit
Fig 3. by Berger et al., CC BY 4.0

PLOS ONE Diagnostic accuracy of two commercial SARS-CoV-2 antigen-detecting rapid tests at the point of care in community-based testing centers
March 31, 2021 Alice Berger, Marie Therese Ngo Nsoga, Francisco Javier Perez-Rodriguez, Yasmine Abi Aad, Pascale Sattonnet-Roche, Angèle Gayet-Ageron, Cyril Jaksic, Giulia Torriani, Erik Boehm, Ilona Kronig, Jilian A. Sacks, Margaretha de Vos, Frédérique Jacquerioz Bausch, François Chappuis, Adriana Renzoni, Laurent Kaiser, Manuel Schibler, Isabella Eckerle

Objectives: Determine the diagnostic accuracy of two antigen-detecting rapid diagnostic tests (Ag-RDT) for SARS-CoV-2 at the point of care…
Image credit
Fig 2. The simulation model structure representing the dynamic interactions of different health state of COVID-19. by Ansah et al., CC BY 4.0

PLOS ONE The effectiveness of public health interventions against COVID-19: Lessons from the Singapore experience
March 30, 2021 John P. Ansah, David Bruce Matchar, Sean Lam Shao Wei, Jenny G. Low, Ahmad Reza Pourghaderi, Fahad Javaid Siddiqui, Tessa Lui Shi Min, Aloysius Chia Wei-Yan, Marcus Eng Hock Ong

Background: In dealing with community spread of COVID-19, two active interventions have been attempted or advocated—containment, and…
Image credit
Fig 2. Adherence to behavioral NPIs to mitigate Covid-19 and subsequent mortality increases over three months in eight countries: (A) Percentage of adult population with strong or very strong self-reported adherence on June 1, 2020; (B) Percentage increase in reported Covid-19 mortality from June 1 to August 31, 2020. by Margraf et al., CC BY 4.0

PLOS ONE Adherence to behavioral Covid-19 mitigation measures strongly predicts mortality
March 30, 2021 Jürgen Margraf, Julia Brailovskaia, Silvia Schneider

In the absence of vaccines or causal therapies, behavioral measures such as wearing face masks and maintaining social distance are central…
Image credit